{ "documentInfo": { "documentType": "https://xbrl.org/2021/xbrl-json", "features": { "xbrl:canonicalValues": true }, "namespaces": { "NXF": "http://nxfiltration.com/2023-12-31", "ifrs-full": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "iso4217": "http://www.xbrl.org/2003/iso4217", "scheme": "http://standards.iso.org/iso/17442", "xbrl": "https://xbrl.org/2021", "xbrli": "http://www.xbrl.org/2003/instance" }, "taxonomy": [ "http://nxfiltration.com/2023-12-31/254900YF0PQV9APMA050-2023-12-31.xsd" ] }, "facts": { "f34674": { "value": "7238000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Revenue", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34677": { "value": "7546000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Revenue", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34685": { "value": "815000", "decimals": -3, "dimensions": { "concept": "ifrs-full:OtherIncome", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34688": { "value": "808000", "decimals": -3, "dimensions": { "concept": "ifrs-full:OtherIncome", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34695": { "value": "8053000", "decimals": -3, "dimensions": { "concept": "ifrs-full:RevenueAndOperatingIncome", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34698": { "value": "8354000", "decimals": -3, "dimensions": { "concept": "ifrs-full:RevenueAndOperatingIncome", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34719": { "value": "2926000", "decimals": -3, "dimensions": { "concept": "ifrs-full:RawMaterialsAndConsumablesUsed", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34722": { "value": "3229000", "decimals": -3, "dimensions": { "concept": "ifrs-full:RawMaterialsAndConsumablesUsed", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34739": { "value": "-3669000", "decimals": -3, "dimensions": { "concept": "ifrs-full:ChangesInInventoriesOfFinishedGoodsAndWorkInProgress", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34742": { "value": "-1134000", "decimals": -3, "dimensions": { "concept": "ifrs-full:ChangesInInventoriesOfFinishedGoodsAndWorkInProgress", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34752": { "value": "12868000", "decimals": -3, "dimensions": { "concept": "ifrs-full:EmployeeBenefitsExpense", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34755": { "value": "8363000", "decimals": -3, "dimensions": { "concept": "ifrs-full:EmployeeBenefitsExpense", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34768": { "value": "679000", "decimals": -3, "dimensions": { "concept": "ifrs-full:AmortisationExpense", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34771": { "value": "490000", "decimals": -3, "dimensions": { "concept": "ifrs-full:AmortisationExpense", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34793": { "value": "3671000", "decimals": -3, "dimensions": { "concept": "ifrs-full:DepreciationExpense", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34796": { "value": "2567000", "decimals": -3, "dimensions": { "concept": "ifrs-full:DepreciationExpense", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34805": { "value": "7268000", "decimals": -3, "dimensions": { "concept": "ifrs-full:OtherExpenseByNature", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34808": { "value": "5602000", "decimals": -3, "dimensions": { "concept": "ifrs-full:OtherExpenseByNature", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34822": { "value": "596000", "decimals": -3, "dimensions": { "concept": "ifrs-full:ResearchAndDevelopmentExpense", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34825": { "value": "843000", "decimals": -3, "dimensions": { "concept": "ifrs-full:ResearchAndDevelopmentExpense", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34831": { "value": "24339000", "decimals": -3, "dimensions": { "concept": "ifrs-full:OperatingExpense", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34834": { "value": "19960000", "decimals": -3, "dimensions": { "concept": "ifrs-full:OperatingExpense", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34845": { "value": "-16286000", "decimals": -3, "dimensions": { "concept": "ifrs-full:ProfitLossFromOperatingActivities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34848": { "value": "-11606000", "decimals": -3, "dimensions": { "concept": "ifrs-full:ProfitLossFromOperatingActivities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34859": { "value": "1939000", "decimals": -3, "dimensions": { "concept": "ifrs-full:FinanceIncomeCost", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34862": { "value": "-289000", "decimals": -3, "dimensions": { "concept": "ifrs-full:FinanceIncomeCost", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34872": { "value": "-14347000", "decimals": -3, "dimensions": { "concept": "ifrs-full:ProfitLossBeforeTax", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34875": { "value": "-11895000", "decimals": -3, "dimensions": { "concept": "ifrs-full:ProfitLossBeforeTax", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34888": { "value": "8945000", "decimals": -3, "dimensions": { "concept": "ifrs-full:IncomeTaxExpenseContinuingOperations", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34891": { "value": "-3253000", "decimals": -3, "dimensions": { "concept": "ifrs-full:IncomeTaxExpenseContinuingOperations", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34901": { "value": "-23292000", "decimals": -3, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34904": { "value": "-8642000", "decimals": -3, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34918": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncome", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34921": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncome", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34931": { "value": "-23292000", "decimals": -3, "dimensions": { "concept": "ifrs-full:ComprehensiveIncome", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34934": { "value": "-8642000", "decimals": -3, "dimensions": { "concept": "ifrs-full:ComprehensiveIncome", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34946": { "value": "-23292000", "decimals": -3, "dimensions": { "concept": "ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34949": { "value": "-8642000", "decimals": -3, "dimensions": { "concept": "ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f34973": { "value": "-0.47", "decimals": 2, "dimensions": { "concept": "ifrs-full:BasicEarningsLossPerShare", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR/xbrli:shares" } }, "f34976": { "value": "-0.17", "decimals": 2, "dimensions": { "concept": "ifrs-full:BasicEarningsLossPerShare", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR/xbrli:shares" } }, "f34988": { "value": "-0.47", "decimals": 2, "dimensions": { "concept": "ifrs-full:DilutedEarningsLossPerShare", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR/xbrli:shares" } }, "f34991": { "value": "-0.17", "decimals": 2, "dimensions": { "concept": "ifrs-full:DilutedEarningsLossPerShare", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR/xbrli:shares" } }, "f35048": { "value": "2637000", "decimals": -3, "dimensions": { "concept": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35051": { "value": "2353000", "decimals": -3, "dimensions": { "concept": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35063": { "value": "57890000", "decimals": -3, "dimensions": { "concept": "ifrs-full:PropertyPlantAndEquipment", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35066": { "value": "18535000", "decimals": -3, "dimensions": { "concept": "ifrs-full:PropertyPlantAndEquipment", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35079": { "value": "1448000", "decimals": -3, "dimensions": { "concept": "ifrs-full:RightofuseAssets", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35082": { "value": "1753000", "decimals": -3, "dimensions": { "concept": "ifrs-full:RightofuseAssets", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35092": { "value": "16000", "decimals": -3, "dimensions": { "concept": "ifrs-full:DeferredTaxAssets", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35095": { "value": "8960000", "decimals": -3, "dimensions": { "concept": "ifrs-full:DeferredTaxAssets", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35108": { "value": "61991000", "decimals": -3, "dimensions": { "concept": "ifrs-full:NoncurrentAssets", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35111": { "value": "31601000", "decimals": -3, "dimensions": { "concept": "ifrs-full:NoncurrentAssets", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35126": { "value": "15063000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Inventories", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35129": { "value": "6305000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Inventories", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35141": { "value": "9057000", "decimals": -3, "dimensions": { "concept": "ifrs-full:TradeAndOtherCurrentReceivables", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35144": { "value": "7154000", "decimals": -3, "dimensions": { "concept": "ifrs-full:TradeAndOtherCurrentReceivables", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35154": { "value": "49928000", "decimals": -3, "dimensions": { "concept": "ifrs-full:CashAndCashEquivalents", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35157": { "value": "104274000", "decimals": -3, "dimensions": { "concept": "ifrs-full:CashAndCashEquivalents", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35168": { "value": "74048000", "decimals": -3, "dimensions": { "concept": "ifrs-full:CurrentAssets", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35171": { "value": "117733000", "decimals": -3, "dimensions": { "concept": "ifrs-full:CurrentAssets", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35182": { "value": "136039000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Assets", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35185": { "value": "149334000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Assets", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35198": { "value": "500000", "decimals": -3, "dimensions": { "concept": "ifrs-full:IssuedCapital", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35201": { "value": "500000", "decimals": -3, "dimensions": { "concept": "ifrs-full:IssuedCapital", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35208": { "value": "170450000", "decimals": -3, "dimensions": { "concept": "ifrs-full:SharePremium", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35211": { "value": "170450000", "decimals": -3, "dimensions": { "concept": "ifrs-full:SharePremium", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35218": { "value": "-51498000", "decimals": -3, "dimensions": { "concept": "ifrs-full:RetainedEarnings", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35221": { "value": "-28412000", "decimals": -3, "dimensions": { "concept": "ifrs-full:RetainedEarnings", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35230": { "value": "119452000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35233": { "value": "142538000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35250": { "value": "951000", "decimals": -3, "dimensions": { "concept": "ifrs-full:NoncurrentLeaseLiabilities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35253": { "value": "1311000", "decimals": -3, "dimensions": { "concept": "ifrs-full:NoncurrentLeaseLiabilities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35267": { "value": "951000", "decimals": -3, "dimensions": { "concept": "ifrs-full:NoncurrentLiabilities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35270": { "value": "1311000", "decimals": -3, "dimensions": { "concept": "ifrs-full:NoncurrentLiabilities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35286": { "value": "15074000", "decimals": -3, "dimensions": { "concept": "ifrs-full:TradeAndOtherCurrentPayables", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35289": { "value": "4988000", "decimals": -3, "dimensions": { "concept": "ifrs-full:TradeAndOtherCurrentPayables", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35298": { "value": "562000", "decimals": -3, "dimensions": { "concept": "ifrs-full:CurrentLeaseLiabilities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35301": { "value": "497000", "decimals": -3, "dimensions": { "concept": "ifrs-full:CurrentLeaseLiabilities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35313": { "value": "15636000", "decimals": -3, "dimensions": { "concept": "ifrs-full:CurrentLiabilities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35316": { "value": "5485000", "decimals": -3, "dimensions": { "concept": "ifrs-full:CurrentLiabilities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35326": { "value": "16587000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Liabilities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35329": { "value": "6796000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Liabilities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35344": { "value": "136039000", "decimals": -3, "dimensions": { "concept": "ifrs-full:EquityAndLiabilities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35347": { "value": "149334000", "decimals": -3, "dimensions": { "concept": "ifrs-full:EquityAndLiabilities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35397": { "value": "500000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:EUR" } }, "f35400": { "value": "170450000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:EUR" } }, "f35403": { "value": "-19806000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:EUR" } }, "f35406": { "value": "151144000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35415": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:EUR" } }, "f35418": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:EUR" } }, "f35421": { "value": "-8642000", "decimals": -3, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:EUR" } }, "f35424": { "value": "-8642000", "decimals": -3, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35435": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncome", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:EUR" } }, "f35438": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncome", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:EUR" } }, "f35441": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncome", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:EUR" } }, "f35444": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncome", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35455": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:ComprehensiveIncome", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:EUR" } }, "f35459": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:ComprehensiveIncome", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:EUR" } }, "f35462": { "value": "-8642000", "decimals": -3, "dimensions": { "concept": "ifrs-full:ComprehensiveIncome", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:EUR" } }, "f35466": { "value": "-8642000", "decimals": -3, "dimensions": { "concept": "ifrs-full:ComprehensiveIncome", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35489": { "value": "0", "decimals": -3, "dimensions": { "concept": "NXF:IssueOfOrdinaryShares", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:EUR" } }, "f35492": { "value": "0", "decimals": -3, "dimensions": { "concept": "NXF:IssueOfOrdinaryShares", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:EUR" } }, "f35495": { "value": "0", "decimals": -3, "dimensions": { "concept": "NXF:IssueOfOrdinaryShares", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:EUR" } }, "f35498": { "value": "0", "decimals": -3, "dimensions": { "concept": "NXF:IssueOfOrdinaryShares", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35512": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:EUR" } }, "f35515": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:EUR" } }, "f35518": { "value": "36000", "decimals": -3, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:EUR" } }, "f35521": { "value": "36000", "decimals": -3, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35528": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:DividendsPaid", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:EUR" } }, "f35531": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:DividendsPaid", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:EUR" } }, "f35534": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:DividendsPaid", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:EUR" } }, "f35537": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:DividendsPaid", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35547": { "value": "500000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:EUR" } }, "f35550": { "value": "170450000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:EUR" } }, "f35553": { "value": "-28412000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:EUR" } }, "f35556": { "value": "142538000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35568": { "value": "500000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:EUR" } }, "f35571": { "value": "170450000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:EUR" } }, "f35574": { "value": "-28412000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:EUR" } }, "f35577": { "value": "142538000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35586": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:EUR" } }, "f35589": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:EUR" } }, "f35592": { "value": "-23292000", "decimals": -3, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:EUR" } }, "f35595": { "value": "-23292000", "decimals": -3, "dimensions": { "concept": "ifrs-full:ProfitLoss", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35607": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncome", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:EUR" } }, "f35610": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncome", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:EUR" } }, "f35613": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncome", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:EUR" } }, "f35616": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:OtherComprehensiveIncome", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35627": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:ComprehensiveIncome", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:EUR" } }, "f35631": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:ComprehensiveIncome", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:EUR" } }, "f35634": { "value": "-23292000", "decimals": -3, "dimensions": { "concept": "ifrs-full:ComprehensiveIncome", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:EUR" } }, "f35638": { "value": "-23292000", "decimals": -3, "dimensions": { "concept": "ifrs-full:ComprehensiveIncome", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35660": { "value": "0", "decimals": -3, "dimensions": { "concept": "NXF:IssueOfOrdinaryShares", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:EUR" } }, "f35663": { "value": "0", "decimals": -3, "dimensions": { "concept": "NXF:IssueOfOrdinaryShares", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:EUR" } }, "f35666": { "value": "0", "decimals": -3, "dimensions": { "concept": "NXF:IssueOfOrdinaryShares", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:EUR" } }, "f35669": { "value": "0", "decimals": -3, "dimensions": { "concept": "NXF:IssueOfOrdinaryShares", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35683": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:EUR" } }, "f35686": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:EUR" } }, "f35689": { "value": "206000", "decimals": -3, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:EUR" } }, "f35692": { "value": "206000", "decimals": -3, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35699": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:DividendsPaid", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:EUR" } }, "f35702": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:DividendsPaid", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:EUR" } }, "f35705": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:DividendsPaid", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:EUR" } }, "f35708": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:DividendsPaid", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f35719": { "value": "500000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:IssuedCapitalMember", "unit": "iso4217:EUR" } }, "f35722": { "value": "170450000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:SharePremiumMember", "unit": "iso4217:EUR" } }, "f35725": { "value": "-51498000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "ifrs-full:ComponentsOfEquityAxis": "ifrs-full:RetainedEarningsMember", "unit": "iso4217:EUR" } }, "f35728": { "value": "119452000", "decimals": -3, "dimensions": { "concept": "ifrs-full:Equity", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "s6_notes__6__13": { "value": "General informationNX Filtration N.V. (NX Filtration or the Company) is a public company with limited liability (naamloze vennootschap), incorporated under Dutch law, and the leading provider of nanofiltration membrane technology for producing pure and affordable water to improve quality of life. NX Filtration obtained its listing on Euronext Amsterdam in June 2021 through an IPO raising \u20ac165 million to enable the Company\u2019s commercial roll-out, capacity expansion program and innovation agenda. NX Filtration is the holding company of the Group, which consists of NX Filtration and, as at 31 December 2023, the following subsidiaries:Subsidiary Domicile Participation and country NX Filtration B.V. Enschede, 100% the Netherlands NX Filtration Enschede, 100% Real Estate B.V. the Netherlands NX Filtration Enschede, 100% International B.V. the Netherlands- NX Filtration Delaware, 100% Americas LLC United States of America- NX Filtration Bangalore, 100% India Private Ltd Republic of India - NX Filtration Beijing, 100% (Beijing) People\u2019s Republic Membrane of China Technology Co Ltd. NX Filtration is registered with the Chamber of Commerce under number 64951030 and has its registered office at Josink Esweg 44, 7545 PN, Enschede, the Netherlands. Both NX Filtration Real Estate B.V. and NX Filtration International B.V. are incorporated and part of the Group per 22 June 2022. The subsidiaries in the United States of America, India and China have been incorporated in the course of 2023.The Company\u2019s financial year covers the first day of January and ends on the last day of December of each year. On 9 February 2024, the management board of NX Filtration (Management Board) authorized the financial statements for publication. The financial statements as presented in this report are subject to adoption by the Annual General Meeting of shareholders to be held on 9 April 2024.", "dimensions": { "concept": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__7": { "value": "NX Filtration N.V.", "dimensions": { "concept": "ifrs-full:NameOfUltimateParentOfGroup", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__6": { "value": "NX Filtration N.V.", "dimensions": { "concept": "ifrs-full:NameOfReportingEntityOrOtherMeansOfIdentification", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__5": { "value": "NX Filtration N.V.", "dimensions": { "concept": "ifrs-full:NameOfParentEntity", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__8": { "value": "public company with limited liability", "dimensions": { "concept": "ifrs-full:LegalFormOfEntity", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__14": { "value": "the leading provider of nanofiltration membrane technology for producing pure and affordable water to improve quality of life", "dimensions": { "concept": "ifrs-full:DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__16": { "value": "NX Filtration is the holding company of the Group, which consists of NX Filtration and, as at 31 December 2023, the following subsidiaries:Subsidiary Domicile Participation and country NX Filtration B.V. Enschede, 100% the Netherlands NX Filtration Enschede, 100% Real Estate B.V. the Netherlands NX Filtration Enschede, 100% International B.V. the Netherlands- NX Filtration Delaware, 100% Americas LLC United States of America- NX Filtration Bangalore, 100% India Private Ltd Republic of India - NX Filtration Beijing, 100% (Beijing) People\u2019s Republic Membrane of China Technology Co Ltd.", "dimensions": { "concept": "ifrs-full:DisclosureOfInterestsInOtherEntitiesExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__15": { "value": "NX Filtration is the holding company of the Group, which consists of NX Filtration and, as at 31 December 2023, the following subsidiaries:Subsidiary Domicile Participation and country NX Filtration B.V. Enschede, 100% the Netherlands NX Filtration Enschede, 100% Real Estate B.V. the Netherlands NX Filtration Enschede, 100% International B.V. the Netherlands- NX Filtration Delaware, 100% Americas LLC United States of America- NX Filtration Bangalore, 100% India Private Ltd Republic of India - NX Filtration Beijing, 100% (Beijing) People\u2019s Republic Membrane of China Technology Co Ltd.", "dimensions": { "concept": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__10": { "value": "Josink Esweg 44, 7545 PN, Enschede, the Netherlands", "dimensions": { "concept": "ifrs-full:PrincipalPlaceOfBusiness", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__9": { "value": "Josink Esweg 44, 7545 PN, Enschede, the Netherlands", "dimensions": { "concept": "ifrs-full:AddressOfRegisteredOfficeOfEntity", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__11": { "value": "Enschede", "dimensions": { "concept": "ifrs-full:DomicileOfEntity", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__12": { "value": "the Netherlands", "dimensions": { "concept": "ifrs-full:CountryOfIncorporation", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__17": { "value": "NX Filtration (Management Board) authorized the financial statements for publication. The financial statements as presented in this report are subject to adoption by the Annual General Meeting of shareholders to be held on 9 April 2024.", "dimensions": { "concept": "ifrs-full:DisclosureOfAuthorisationOfFinancialStatementsExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__19": { "value": "Summary of significant accounting policiesThe principal accounting policies applied in the preparation of these consolidated financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.Basis of preparationThese consolidated financial statements have been prepared in accordance, and comply with International Financial Reporting Standards (IFRS) and interpretations adopted by the European Union, where effective, for financial years beginning 1 January 2023 and also comply with the financial reporting requirements included in Part 9 of Book 2 of the Dutch Civil Code. The preparation of these consolidated financial statements in conformity with IFRS requires the use of certain critical accounting estimates. It also requires management to exercise its judgment in the process of applying the Company\u2019s accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the financial statements are disclosed in note 6 \u2018Critical accounting estimates and judgements\u2019.These consolidated financial statements have been prepared on a going concern basis. In June 2021, NX Filtration became a publicly traded company when it listed its ordinary shares on Euronext Amsterdam, raising \u20ac165 million for inter alia the acceleration of its business plan including a medium-term objective to realize a positive EBITDA margin by reaching a larger scale of operations and realizing purchasing benefits based on increasing volumes and optimizing product designs.Going Concern assessmentThe Company is a global provider of direct nanofiltration membrane technology, focused on the discovery, development and commercialization of innovative technologies to remove micropollutants, color and selective salts, but also bacteria, viruses and nano plastic, from water. In recent years, the Company has been incurring losses mainly due to ahead of the curve investments to roll out their commercial strategy, create global sales presence, further develop the disruptive dNF technology and extend the production capacity to facilitate the expected growth in revenue. The Company relies on the capital raised to finance the roll out of the business strategy and ahead of the curve investments.The Company incurred net losses of \u20ac 23.3 million (2022: \u20ac 8.6 million) and negative operating cash flows of \u20ac 11.7 million (2022: \u20ac 15.7 million). Per 31 December 2023, the cash balance amounts \u20ac 49.9 million (2022: \u20ac 104.3 million). Although Management expects that the cash balance is sufficient to finance the required capital expenditure and operations for the next twelve months period after the date of this report, it considered scenarios where the current financial position may not be sufficient to finance its operations. The Company\u2019s ability to continue as a going concern is highly contingent upon its ability to execute on the successful roll out of its business strategy and to remain flexible in order to mitigate unforeseen circumstances that will impact the profitability of the Company. Management performed a sensitivity analyses on sales forecasts and options for cost reductions and savings on capital expenditure.2024 is considered to be a year where the business model of the Company further matures and the Company will start benefitting from the investment made in pilot trajectories, growing OEM customer base, investment in technology and sales organization. The business and sales developments are progressing and are converting opportunities into new agreements with OEM\u2019s for the sale of membranes which could potentially result to additional operating cash inflows. The Company has a clear plan to become cash-flow positive on medium term. Although management expects that there is sufficient cash available to fund the activities for the twelve months period after signing these financial statements, additional financing needs to be attracted to bridge the period until the Company becomes cash flow positive. Therefore, management is actively engaged in exploring various funding sources such as an asset-based financing plan. Management is confident that it will be able to attract this funding, as currently the Company has no external funding on their large asset-base. Based on progress of ongoing initiatives above, the accounting policies used in the financial statements are based on the expectation that the Company will be able to continue as a going concern. Basis of measurementThese consolidated financial statements have been prepared on a historical cost basis, unless stated otherwise. These consolidated financial statements are presented in euro, which is the Company\u2019s functional currency. All amounts have been rounded to the nearest thousand, unless otherwise indicated.New and amended standards not adopted by the GroupCertain new accounting standards and interpretations have been published that are not mandatory for 31 December 2023 reporting periods and have not been early adopted by the Group. These standards are not expected to have a material impact on the entity in the current or future reporting periods and on foreseeable future transactions.", "dimensions": { "concept": "ifrs-full:DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__18-1": { "value": "Summary of significant accounting policiesThe principal accounting policies applied in the preparation of these consolidated financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.Basis of preparationThese consolidated financial statements have been prepared in accordance, and comply with International Financial Reporting Standards (IFRS) and interpretations adopted by the European Union, where effective, for financial years beginning 1 January 2023 and also comply with the financial reporting requirements included in Part 9 of Book 2 of the Dutch Civil Code. The preparation of these consolidated financial statements in conformity with IFRS requires the use of certain critical accounting estimates. It also requires management to exercise its judgment in the process of applying the Company\u2019s accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the financial statements are disclosed in note 6 \u2018Critical accounting estimates and judgements\u2019.These consolidated financial statements have been prepared on a going concern basis. In June 2021, NX Filtration became a publicly traded company when it listed its ordinary shares on Euronext Amsterdam, raising \u20ac165 million for inter alia the acceleration of its business plan including a medium-term objective to realize a positive EBITDA margin by reaching a larger scale of operations and realizing purchasing benefits based on increasing volumes and optimizing product designs.Going Concern assessmentThe Company is a global provider of direct nanofiltration membrane technology, focused on the discovery, development and commercialization of innovative technologies to remove micropollutants, color and selective salts, but also bacteria, viruses and nano plastic, from water. In recent years, the Company has been incurring losses mainly due to ahead of the curve investments to roll out their commercial strategy, create global sales presence, further develop the disruptive dNF technology and extend the production capacity to facilitate the expected growth in revenue. The Company relies on the capital raised to finance the roll out of the business strategy and ahead of the curve investments.The Company incurred net losses of \u20ac 23.3 million (2022: \u20ac 8.6 million) and negative operating cash flows of \u20ac 11.7 million (2022: \u20ac 15.7 million). Per 31 December 2023, the cash balance amounts \u20ac 49.9 million (2022: \u20ac 104.3 million). Although Management expects that the cash balance is sufficient to finance the required capital expenditure and operations for the next twelve months period after the date of this report, it considered scenarios where the current financial position may not be sufficient to finance its operations. The Company\u2019s ability to continue as a going concern is highly contingent upon its ability to execute on the successful roll out of its business strategy and to remain flexible in order to mitigate unforeseen circumstances that will impact the profitability of the Company. Management performed a sensitivity analyses on sales forecasts and options for cost reductions and savings on capital expenditure.2024 is considered to be a year where the business model of the Company further matures and the Company will start benefitting from the investment made in pilot trajectories, growing OEM customer base, investment in technology and sales organization. The business and sales developments are progressing and are converting opportunities into new agreements with OEM\u2019s for the sale of membranes which could potentially result to additional operating cash inflows. The Company has a clear plan to become cash-flow positive on medium term. Although management expects that there is sufficient cash available to fund the activities for the twelve months period after signing these financial statements, additional financing needs to be attracted to bridge the period until the Company becomes cash flow positive. Therefore, management is actively engaged in exploring various funding sources such as an asset-based financing plan. Management is confident that it will be able to attract this funding, as currently the Company has no external funding on their large asset-base. Based on progress of ongoing initiatives above, the accounting policies used in the financial statements are based on the expectation that the Company will be able to continue as a going concern. Basis of measurementThese consolidated financial statements have been prepared on a historical cost basis, unless stated otherwise. These consolidated financial statements are presented in euro, which is the Company\u2019s functional currency. All amounts have been rounded to the nearest thousand, unless otherwise indicated.New and amended standards not adopted by the GroupCertain new accounting standards and interpretations have been published that are not mandatory for 31 December 2023 reporting periods and have not been early adopted by the Group. These standards are not expected to have a material impact on the entity in the current or future reporting periods and on foreseeable future transactions.Critical accounting policiesConsolidation Subsidiaries are all entities over which the Company has control. The Company controls an entity where the Company is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power to direct the activities of the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. Subsidiaries are deconsolidated from the date that control ceases.Inter-company transactions, balances and unrealized gains on transactions between group companies are eliminated. Unrealized losses are also eliminated unless the transaction provides evidence of an impairment of the transferred asset. Accounting policies of subsidiaries have been changed where necessary to ensure consistency with the policies adopted by the Group. Foreign currency transactions and translationsForeign currency transactions are translated into the functional currency of the Company using the exchange rates at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions, and from the translation of monetary assets and liabilities denominated in foreign currencies at year-end exchange rates, are generally recognized in profit or loss.The assets and liabilities of foreign operations are translated into euro at the exchange rates on the reporting date. The income and expenses of foreign operations are translated into euro at the exchange rates on the date of transactions.RevenueThe Company manufactures and sells a range of water filtration solutions to companies serving the industrial and municipal sectors. Sales are recognized when control of the products has transferred, being when the products are delivered or risks are transferred to the customers, the customer has full discretion over the use of the products, and there is no unfulfilled obligation that could affect the customer\u2019s acceptance of the products. Delivery occurs when the products have been shipped to the specific location, the risks of obsolescence and loss have been transferred to the customer, and either the customer has accepted the products in accordance with the sales contract, the acceptance provisions have lapsed, or the Company has objective evidence that all criteria for acceptance have been satisfied. Revenue is measured based on the consideration specified in a contract with a customer. The Company has no specific obligations for returns, refund clauses nor any other similar obligations specified in the contract with customers. However, standard product compliance warranty is provided to customers, which is not considered a separate performance obligation.Government grantsGrants from the government are recognized at their fair value where there is a reasonable assurance that the grant will be received, and the Company will comply with all attached conditions. Government grants relating to costs are deferred and recognized in the statement of comprehensive income over the period necessary to match them with the costs they are intended to compensate.Employee benefitsShort-term obligationsLiabilities for wages and salaries, including non-monetary benefits, annual leave and accumulating sick leave that are expected to be settled fully within 12 months after the end of the period in which the employees render the related service are recognized in respect of employees\u2019 services up to the end of the reporting period and are measured at the amounts expected to be paid when the liabilities are settled. The liabilities are presented as current employee benefit obligations in the balance sheet. Salaries, wages and social security contributions are charged to the consolidated statement of comprehensive income based on the terms of employment, when they are due to employees and the tax authorities respectively.Pension obligationsFor defined contribution plans, the Company pays contributions to publicly or privately administered pension insurance plans on a mandatory, contractual or voluntary basis. The Company has no further payment obligations once the contributions have been paid. The contributions are recognized as employee benefit expense when they are due. Prepaid contributions are recognized as an asset to the extent that a cash refund or a reduction in the future payments is available. Termination benefits are expensed at the earlier of when the Company can no longer withdraw the offer of those benefits and when the Company recognizes costs for a restructuring.Shared-based payments The grant-date fair value of equity-settled share-based payment awards granted to employees is recognized as an expense, with a corresponding increase in equity, over the vesting period of the awards. The amount recognized as an expense is adjusted to reflect the number of awards for which the related service and non-market performance conditions are expected to be met, such that the amount ultimately recognized is based on the number of awards that meet the related service and non-market performance conditions at the vesting date. The Company has no share-based payment awards with non-vesting conditions nor with market performance conditions.Expenses Expenses arising from the Company\u2019s business operations are accounted for in the year incurred.Finance income & expensesFinance income include interest where it is earned from financial assets that are held for cash management purposes. Finance expenses include interest incurred on financial instruments measured at amortized cost. Finance income or expenses are recognized as they accrue, using the effective interest method.Corporate income tax The income tax expense or credit for the period is the tax payable on the current period\u2019s taxable income, based on the applicable income tax rate for each jurisdiction, adjusted by changes in deferred tax assets and liabilities attributable to temporary differences and to unused tax losses.The current income tax charge (if applicable) is calculated on the basis of the tax laws enacted or substantively enacted at the end of the reporting period in the countries where the group companies operate and generate taxable income. Management periodically evaluates positions taken in tax returns with respect to situations in which applicable tax regulation is subject to interpretation and considers whether it is probable that a taxation authority will accept an uncertain tax treatment. The Company measures its tax balances either based on the most likely amount or the expected value, depending on which method provides a better prediction of the resolution of the uncertainty. Deferred income tax is provided in full, using the liability method, on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the consolidated financial statements. Deferred income tax is determined using tax rates (and laws) that have been enacted or substantively enacted by the end of the reporting period and are expected to apply when the related deferred income tax asset is realized, or the deferred income tax liability is settled. Deferred tax assets are recognized only if it is probable that future taxable amounts will be available to utilize those temporary differences and losses. Current and deferred tax is recognized in profit or loss, except to the extent that it relates to items recognized in other comprehensive income or directly in equity. In this case, the tax is also recognized in other comprehensive income or directly in equity, respectively.Intangible assetsResearch and developmentDevelopment costs that are directly attributable to the design and testing of identifiable and unique products controlled by the Company are recognized as intangible assets where the following criteria are met: \u2022 it is technically feasible to complete the product or system so that it will be available for use;\u2022 management intends to complete the product or system and use or sell it;\u2022 there is an ability to use or sell the product or system;\u2022 it can be demonstrated how the product or system will generate probable future economic benefits;\u2022 adequate technical, financial and other resources to complete the development and to use or sell the product or system are available; and\u2022 the expenditure attributable to the product or system during its development can be reliably measured.Directly attributable costs that are capitalized as part of the product include amongst others payroll costs and other costs related to creating or improving the existing product portfolio in the development phase.Capitalized development costs are recorded as intangible assets and amortized in 5 years from the point at which the asset is ready for use. Other development expenditures that do not meet these criteria are recognized as an expense as incurred. Development costs previously recognized as an expense are not recognized as an asset in a subsequent period. Expenditure on research activities is recognized as expense in the period in which it is incurred.Concessions, licenses and rights to intellectual property Concessions, licenses and rights to intellectual property are capitalized at historical cost. They have a finite useful life and are subsequently carried at cost less accumulated amortization and impairment losses. These assets are amortized over a period of 10 years.SoftwareSoftware are capitalized at historical cost and amortized on a straight-line basis over the estimated useful life of the assets, typically 3 years. Cost associated with maintaining software programs are recognized as an expense as incurred. Property, plant and equipmentAll property, plant and equipment is stated at historical cost less depreciation. Historical cost includes expenditure that is directly attributable to the acquisition of the items. Subsequent costs are included in the asset\u2019s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of any component accounted for as a separate asset is derecognized when replaced. All other repairs and maintenance are charged to profit or loss during the reporting period in which they are incurred.Depreciation on assets is calculated by recognizing the difference between historical cost and the estimated residual values using the straight-line method over their estimated useful life in profit or loss.The estimated useful lives of property, plant and equipment for current and comparable periods are as follows: Buildings 10 - 30 yearsMachinery and equipment 5 - 10 years Right-of-use assets 1 - 9 years Pilot equipment 5 years The assets\u2019 residual values and useful lives are reviewed, and adjusted if appropriate, at the end of each reporting period. The costs of future replacement are capitalized based on the component approach. Under this approach the total costs are allocated to the \u2018component assets\u2019. Government grants on investments, if applicable, are deducted from the purchase price or manufacturing price of the assets to which the government grants relate.An asset\u2019s carrying amount is written down immediately to its recoverable amount if the asset\u2019s carrying amount is greater than its estimated recoverable amount.Gains and losses on disposals are determined by comparing proceeds with the carrying amount and are recognized within the consolidated statement of comprehensive income.Leases As a lesseeAt the inception of an agreement, the Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. To assess whether a contract conveys the right to control the use of an identified asset, the Company uses the definition of a lease in IFRS 16.The Company, as a lessee, recognizes a right-of-use asset representing its right to use the underlying asset and a lease liability representing its obligation to make lease payments at the lease commencement date.The Company elected to apply the recognition exemption for both short-term and low value leases \u2013 e.g. office equipment. As such, the Company recognizes lease payments associated with these leases as an expense on a straight-line basis over the lease term.The right-of-use asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle and remove the underlying asset or to restore the underlying asset or the site on which it is located, less any lease incentives received.The right-of-use asset is subsequently depreciated using the straight-line method from the commencement date to the end of the lease term, unless the lease transfers ownership of the underlying asset to the Company by the end of the lease term or the cost of the right-of-use asset reflects that the Company will exercise a purchase option. In that case the right-of-use asset will be depreciated over the useful life of the underlying asset, which is determined on the same basis as those of property, plant and equipment. In addition, the right-of- use asset is periodically reduced by impairment losses, if any, and adjusted for certain remeasurements of the lease liability.The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company\u2019s incremental borrowing rate. Subsequently, the lease liability is increased by the interest costs on the lease liability and decreased by lease payments made.Lease payments included in the measurement of the lease liability comprise the following:\u2022 fixed payments, including in-substance fixed payments;\u2022 variable lease payments that depend on an index or a rate, initially measured using the index or rate as at the commencement date;\u2022 amounts expected to be payable under a residual value guarantee; and\u2022 the exercise price under a purchase option that the Company is reasonably certain to exercise, lease payments in an optional renewal period if the Company is reasonably certain to exercise an extension option, and penalties for early termination of a lease unless the Company is reasonably certain not to terminate early.The lease liability is measured at amortized cost using the effective interest method. The lease liability is remeasured when there is a change in future lease payments arising from a change in index or rate, a change in the estimate of the amount expected to be payable under a residual value guarantee, or as appropriate, changes in the assessment whether a purchase or renewal option is reasonably certain to be exercised or a termination option is reasonably certain not to be exercised.When the lease liability is remeasured as abovementioned, a corresponding adjustment is made to the carrying amount of the right-of-use asset or is recorded in profit or loss if the carrying amount of the right-of-use asset has been reduced to zero.The Company\u2019s right-of-use assets and lease liabilities are presented under Property, plant and equipment and Lease liabilities, respectively.As a lessorLeases in which the Company does not transfer substantially all the risks and rewards incidental to ownership of an asset are classified as operating leases. The Company has rental income from the lease of pilot equipment. This rental income is accounted for on a straight-line basis over the lease terms and is included in gross income in the statement of comprehensive income. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognized over the lease term on the same basis as rental income. Contingent rents are recognized as gross income in the period in which they are earned.Impairment of non-financial assets Non-financial assets with a definite useful life are tested for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognized for the amount by which the asset\u2019s carrying amount exceeds its recoverable amount. The recoverable amount is the higher of an asset\u2019s fair value less costs of disposal and value in use. For the purposes of assessing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash inflows which are largely independent of the cash inflows from other assets or groups of assets (cash-generating units). Non-financial assets that suffered an impairment are reviewed for possible reversal of the impairment at the end of each reporting period. Inventories Inventories mainly relate to raw materials, semi-finished goods, work in progress and finished goods and are valued at the lower of cost and net realizable value. Cost comprises direct materials, direct labour and an appropriate proportion of variable and fixed overhead expenditure, the latter being allocated on the basis of normal operating capacity. Costs of purchased inventory are determined after deducting rebates and discounts. Costs are determined using the first in first out method. Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Financial instruments Financial assets \u2013 Classification and measurementThe Company classifies its financial assets in the following measurement categories:\u2022 those to be measured subsequently at fair value (either through other comprehensive Income (OCI) or through profit or loss), and\u2022 those to be measured at amortized cost.The classification depends on the entity\u2019s business model for managing the financial assets and the contractual terms of the cash flows.Financial assets - Recognition and derecognitionRegular purchases and sales of financial assets are recognized on the trade-date, the date on which the Company commits to purchase or sell the asset. Financial assets are derecognized when the rights to receive cash flows from the financial assets have expired or have been transferred and the Company has transferred substantially all the risks and rewards of ownership.Financial assets \u2013 Initial recognitionAt initial recognition the Company measures a financial asset at its fair value. Except for cash and cash equivalents, the initial measurement of a financial asset is adjusted for directly attributable transaction cost. Transaction costs of financial assets carried at fair value through profit or loss (cash and cash equivalents) are expensed in profit or loss.Financial assets \u2013 Subsequent MeasurementsSubsequent measurement depends on the Company\u2019s business model for managing the asset and the cash flow characteristics of the asset. There are three measurement categories into which the Company classifies its debt instruments: (i) Amortized cost, (ii) Fair value through profit or loss; and (iii) Fair value through other comprehensive income.The Company makes no use of derivative financial instruments. Besides cash and cash equivalents that are measured at fair value through profit or loss, the Company\u2019s receivables are measured at amortized costs. Interest income (if any) from these financial assets is included in finance income using the effective interest rate method. Any gain or loss arising on derecognition is recognized directly in profit or loss.Financial assets \u2013 ImpairmentThe Company assesses on a forward-looking basis the expected credit losses associated with its financial instruments carried at amortized cost. The impairment methodology applied depends on whether there has been a significant increase in credit risk. The Company has no trade receivables nor amounts due from customers for contract work including a significant finance component and is therefore allowed to apply the simplified approach under IFRS 9, in which the credit losses are measured using a lifetime expected loss allowance for all trade receivables. Financial liabilities - Recognition and measurementFinancial liabilities are recognized when the Company becomes a party to the contractual provisions of the financial instrument. The Company only has financial liabilities at amortized cost and makes no use of derivative financial instruments.Financial liabilities at amortized costsFinancial liabilities at amortized cost include trade and other payables. Trade and other payables are initially recognized at fair value equaling the amount required to be paid, less, when material, a discount to reduce the payables to fair value. Subsequently, trade and other payables are measured at amortized cost using the effective interest method. Trade and other payables are classified as current liabilities due to their short-term nature, except for maturities greater than 12 months after the end of the reporting period. These are classified as non-current liabilities.Financial liabilities \u2013 DerecognitionThe Company derecognizes a financial liability when its contractual obligations are discharged or cancelled or expire. On derecognition of a financial liability, the difference between the carrying amount extinguished and the consideration paid (including any non-cash assets transferred or liabilities assumed) is recognized in the consolidated statement of comprehensive income.The Company also derecognizes a financial liability when its terms are modified and the cash flows of the modified liability are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. However, when the cash flows of the modified liability are not substantially different, the Company (i) recalculates the amortized cost of the modified financial liability by discounting the modified contractual cash flows using the original effective interest rate and (ii) recognizes any adjustment in the consolidated statement of comprehensive income.Offsetting financial instrumentsFinancial assets and liabilities are offset and the net amount reported in the balance sheet when there is a legally enforceable right to offset the recognized amounts and there is an intention to settle on a net basis or realize the asset and settle the liability simultaneously. The Company does not have any legally enforceable right to offset the recognized amounts in the balance sheet.Trade and other receivables Trade and other receivables are amounts due from customers for products delivered and services performed in the ordinary course of business. If collection is expected in one year or less, they are classified as current assets. If not, they are presented as non-current assets. Trade receivables are generally due for settlement immediately and therefore all classified as current assets.Trade receivables are recognized initially at their transaction price, the amount of consideration that is unconditional, unless they contain significant financing components when they are recognized at fair value. They are subsequently measured at amortized cost using the effective interest method, less loss allowance. Cash and cash equivalents For the purpose of presentation in the statement of cash flows, cash and cash equivalents includes cash on hand, deposits held at call with financial institutions, other short-term, highly liquid investments with original maturities of three months or less that are readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value. Cash and cash equivalents are measured at fair value.Share capital \u2013 Ordinary sharesAn ordinary share entitles its owner to a voting right and, only to extent so ultimately decided by the general meeting of the Company (the General Meeting), to dividends. Trade and other payables These amounts represent liabilities provided to the Company prior to the end of the financial year which are unpaid. Trade and other payables are presented as current liabilities unless payment is not due within 12 months after the reporting period. They are recognized initially at their fair value. And subsequent measurement at amortized cost using the effective interest method.Cash flow statement The cash flow statement has been prepared using the indirect method, whereby profit or loss is adjusted for the effects of transactions of a non-cash nature, any deferrals or accruals of past or future operating cash receipts or payments, and items of income or expense associated with investing or financing cash flows. Segment reportingThe Company is engaged in the business of developing, producing and selling hollow fiber membrane modules. NX Filtration sells its filtration membranes in the form of modules in its two business lines: Clean Municipal Water and Sustainable Industrial Water. As there is a strong interrelationship between NX Filtration\u2019s activities and these business lines, management reviews the profitability and monitors the performance of the two business lines, despite the split in revenue, solely on an aggregated basis for resource allocation and overall performance measurement", "dimensions": { "concept": "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__20": { "value": "These consolidated financial statements have been prepared in accordance, and comply with International Financial Reporting Standards (IFRS) and interpretations adopted by the European Union, where effective, for financial years beginning 1 January 2023", "dimensions": { "concept": "ifrs-full:StatementOfIFRSCompliance", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "f36350": { "value": "-16286000", "decimals": -3, "dimensions": { "concept": "ifrs-full:ProfitLossFromOperatingActivities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36353": { "value": "-11606000", "decimals": -3, "dimensions": { "concept": "ifrs-full:ProfitLossFromOperatingActivities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36380": { "value": "4350000", "decimals": -3, "dimensions": { "concept": "ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36383": { "value": "3057000", "decimals": -3, "dimensions": { "concept": "ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36395": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:OtherAdjustmentsForNoncashItems", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36398": { "value": "126000", "decimals": -3, "dimensions": { "concept": "ifrs-full:OtherAdjustmentsForNoncashItems", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36410": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:AdjustmentsForProvisions", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36413": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:AdjustmentsForProvisions", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36426": { "value": "206000", "decimals": -3, "dimensions": { "concept": "ifrs-full:AdjustmentsForSharebasedPayments", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36429": { "value": "36000", "decimals": -3, "dimensions": { "concept": "ifrs-full:AdjustmentsForSharebasedPayments", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36444": { "value": "-8263000", "decimals": -3, "dimensions": { "concept": "ifrs-full:AdjustmentsForDecreaseIncreaseInInventories", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36447": { "value": "-3093000", "decimals": -3, "dimensions": { "concept": "ifrs-full:AdjustmentsForDecreaseIncreaseInInventories", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36460": { "value": "-1903000", "decimals": -3, "dimensions": { "concept": "ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36463": { "value": "-4350000", "decimals": -3, "dimensions": { "concept": "ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36475": { "value": "10152000", "decimals": -3, "dimensions": { "concept": "ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36478": { "value": "128000", "decimals": -3, "dimensions": { "concept": "ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36489": { "value": "-11744000", "decimals": -3, "dimensions": { "concept": "ifrs-full:CashFlowsFromUsedInOperatingActivities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36492": { "value": "-15702000", "decimals": -3, "dimensions": { "concept": "ifrs-full:CashFlowsFromUsedInOperatingActivities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36515": { "value": "42977000", "decimals": -3, "dimensions": { "concept": "ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36518": { "value": "11653000", "decimals": -3, "dimensions": { "concept": "ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36529": { "value": "963000", "decimals": -3, "dimensions": { "concept": "ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36532": { "value": "1017000", "decimals": -3, "dimensions": { "concept": "ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36550": { "value": "-43940000", "decimals": -3, "dimensions": { "concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36553": { "value": "-12670000", "decimals": -3, "dimensions": { "concept": "ifrs-full:CashFlowsFromUsedInInvestingActivities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36579": { "value": "0", "decimals": -3, "dimensions": { "concept": "NXF:ProceedsFromIssuingSharesAndSharePremiumContribution", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36582": { "value": "0", "decimals": -3, "dimensions": { "concept": "NXF:ProceedsFromIssuingSharesAndSharePremiumContribution", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36596": { "value": "600000", "decimals": -3, "dimensions": { "concept": "ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36599": { "value": "465000", "decimals": -3, "dimensions": { "concept": "ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36609": { "value": "-1938000", "decimals": -3, "dimensions": { "concept": "ifrs-full:InterestPaidClassifiedAsFinancingActivities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36612": { "value": "322000", "decimals": -3, "dimensions": { "concept": "ifrs-full:InterestPaidClassifiedAsFinancingActivities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36628": { "value": "1338000", "decimals": -3, "dimensions": { "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36631": { "value": "-787000", "decimals": -3, "dimensions": { "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36650": { "value": "-54346000", "decimals": -3, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36653": { "value": "-29159000", "decimals": -3, "dimensions": { "concept": "ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36671": { "value": "104274000", "decimals": -3, "dimensions": { "concept": "ifrs-full:CashAndCashEquivalents", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36674": { "value": "133433000", "decimals": -3, "dimensions": { "concept": "ifrs-full:CashAndCashEquivalents", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36692": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36695": { "value": "0", "decimals": -3, "dimensions": { "concept": "ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents", "entity": "scheme:254900YF0PQV9APMA050", "period": "2022-01-01T00:00:00/2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36712": { "value": "49928000", "decimals": -3, "dimensions": { "concept": "ifrs-full:CashAndCashEquivalents", "entity": "scheme:254900YF0PQV9APMA050", "period": "2024-01-01T00:00:00", "unit": "iso4217:EUR" } }, "f36715": { "value": "104274000", "decimals": -3, "dimensions": { "concept": "ifrs-full:CashAndCashEquivalents", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00", "unit": "iso4217:EUR" } }, "s6_notes__6__22": { "value": "The preparation of these consolidated financial statements in conformity with IFRS requires the use of certain critical accounting estimates. It also requires management to exercise its judgment in the process of applying the Company\u2019s accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the financial statements are disclosed in note 6 \u2018Critical accounting estimates and judgements", "dimensions": { "concept": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__21": { "value": "These consolidated financial statements have been prepared on a going concern basis. In June 2021, NX Filtration became a publicly traded company when it listed its ordinary shares on Euronext Amsterdam, raising \u20ac165 million for inter alia the acceleration of its business plan including a medium-term objective to realize a positive EBITDA margin by reaching a larger scale of operations and realizing purchasing benefits based on increasing volumes and optimizing product designs.Going Concern assessmentThe Company is a global provider of direct nanofiltration membrane technology, focused on the discovery, development and commercialization of innovative technologies to remove micropollutants, color and selective salts, but also bacteria, viruses and nano plastic, from water. In recent years, the Company has been incurring losses mainly due to ahead of the curve investments to roll out their commercial strategy, create global sales presence, further develop the disruptive dNF technology and extend the production capacity to facilitate the expected growth in revenue. The Company relies on the capital raised to finance the roll out of the business strategy and ahead of the curve investments.The Company incurred net losses of \u20ac 23.3 million (2022: \u20ac 8.6 million) and negative operating cash flows of \u20ac 11.7 million (2022: \u20ac 15.7 million). Per 31 December 2023, the cash balance amounts \u20ac 49.9 million (2022: \u20ac 104.3 million). Although Management expects that the cash balance is sufficient to finance the required capital expenditure and operations for the next twelve months period after the date of this report, it considered scenarios where the current financial position may not be sufficient to finance its operations. The Company\u2019s ability to continue as a going concern is highly contingent upon its ability to execute on the successful roll out of its business strategy and to remain flexible in order to mitigate unforeseen circumstances that will impact the profitability of the Company. Management performed a sensitivity analyses on sales forecasts and options for cost reductions and savings on capital expenditure.2024 is considered to be a year where the business model of the Company further matures and the Company will start benefitting from the investment made in pilot trajectories, growing OEM customer base, investment in technology and sales organization. The business and sales developments are progressing and are converting opportunities into new agreements with OEM\u2019s for the sale of membranes which could potentially result to additional operating cash inflows. The Company has a clear plan to become cash-flow positive on medium term. Although management expects that there is sufficient cash available to fund the activities for the twelve months period after signing these financial statements, additional financing needs to be attracted to bridge the period until the Company becomes cash flow positive. Therefore, management is actively engaged in exploring various funding sources such as an asset-based financing plan. Management is confident that it will be able to attract this funding, as currently the Company has no external funding on their large asset-base. Based on progress of ongoing initiatives above, the accounting policies used in the financial statements are based on the expectation that the Company will be able to continue as a going concern.", "dimensions": { "concept": "ifrs-full:DisclosureOfGoingConcernExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__25": { "value": "Consolidation Subsidiaries are all entities over which the Company has control. The Company controls an entity where the Company is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power to direct the activities of the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. Subsidiaries are deconsolidated from the date that control ceases.Inter-company transactions, balances and unrealized gains on transactions between group companies are eliminated. Unrealized losses are also eliminated unless the transaction provides evidence of an impairment of the transferred asset. Accounting policies of subsidiaries have been changed where necessary to ensure consistency with the policies adopted by the Group.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForSubsidiariesExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__24": { "value": "Consolidation Subsidiaries are all entities over which the Company has control. The Company controls an entity where the Company is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power to direct the activities of the entity. Subsidiaries are fully consolidated from the date on which control is transferred to the Company. Subsidiaries are deconsolidated from the date that control ceases.Inter-company transactions, balances and unrealized gains on transactions between group companies are eliminated. Unrealized losses are also eliminated unless the transaction provides evidence of an impairment of the transferred asset. Accounting policies of subsidiaries have been changed where necessary to ensure consistency with the policies adopted by the Group.", "dimensions": { "concept": "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__26": { "value": "Foreign currency transactions and translationsForeign currency transactions are translated into the functional currency of the Company using the exchange rates at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions, and from the translation of monetary assets and liabilities denominated in foreign currencies at year-end exchange rates, are generally recognized in profit or loss.The assets and liabilities of foreign operations are translated into euro at the exchange rates on the reporting date. The income and expenses of foreign operations are translated into euro at the exchange rates on the date of transactions.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__27": { "value": "RevenueThe Company manufactures and sells a range of water filtration solutions to companies serving the industrial and municipal sectors. Sales are recognized when control of the products has transferred, being when the products are delivered or risks are transferred to the customers, the customer has full discretion over the use of the products, and there is no unfulfilled obligation that could affect the customer\u2019s acceptance of the products. Delivery occurs when the products have been shipped to the specific location, the risks of obsolescence and loss have been transferred to the customer, and either the customer has accepted the products in accordance with the sales contract, the acceptance provisions have lapsed, or the Company has objective evidence that all criteria for acceptance have been satisfied. Revenue is measured based on the consideration specified in a contract with a customer. The Company has no specific obligations for returns, refund clauses nor any other similar obligations specified in the contract with customers. However, standard product compliance warranty is provided to customers, which is not considered a separate performance obligation.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__28": { "value": "Government grantsGrants from the government are recognized at their fair value where there is a reasonable assurance that the grant will be received, and the Company will comply with all attached conditions. Government grants relating to costs are deferred and recognized in the statement of comprehensive income over the period necessary to match them with the costs they are intended to compensate.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__29": { "value": "Employee benefitsShort-term obligationsLiabilities for wages and salaries, including non-monetary benefits, annual leave and accumulating sick leave that are expected to be settled fully within 12 months after the end of the period in which the employees render the related service are recognized in respect of employees\u2019 services up to the end of the reporting period and are measured at the amounts expected to be paid when the liabilities are settled. The liabilities are presented as current employee benefit obligations in the balance sheet. Salaries, wages and social security contributions are charged to the consolidated statement of comprehensive income based on the terms of employment, when they are due to employees and the tax authorities respectively.Pension obligationsFor defined contribution plans, the Company pays contributions to publicly or privately administered pension insurance plans on a mandatory, contractual or voluntary basis. The Company has no further payment obligations once the contributions have been paid. The contributions are recognized as employee benefit expense when they are due. Prepaid contributions are recognized as an asset to the extent that a cash refund or a reduction in the future payments is available. Termination benefits are expensed at the earlier of when the Company can no longer withdraw the offer of those benefits and when the Company recognizes costs for a restructuring.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__30": { "value": "Termination benefits are expensed at the earlier of when the Company can no longer withdraw the offer of those benefits and when the Company recognizes costs for a restructuring", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForTerminationBenefits", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__31": { "value": "Shared-based payments The grant-date fair value of equity-settled share-based payment awards granted to employees is recognized as an expense, with a corresponding increase in equity, over the vesting period of the awards. The amount recognized as an expense is adjusted to reflect the number of awards for which the related service and non-market performance conditions are expected to be met, such that the amount ultimately recognized is based on the number of awards that meet the related service and non-market performance conditions at the vesting date. The Company has no share-based payment awards with non-vesting conditions nor with market performance conditions.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__32": { "value": "Expenses Expenses arising from the Company\u2019s business operations are accounted for in the year incurred.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForExpensesExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__34": { "value": "Finance income & expensesFinance income include interest where it is earned from financial assets that are held for cash management purposes. Finance expenses include interest incurred on financial instruments measured at amortized cost. Finance income or expenses are recognized as they accrue, using the effective interest method.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForFinanceCostsExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__33": { "value": "Finance income & expensesFinance income include interest where it is earned from financial assets that are held for cash management purposes. Finance expenses include interest incurred on financial instruments measured at amortized cost. Finance income or expenses are recognized as they accrue, using the effective interest method.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__35": { "value": "Corporate income tax The income tax expense or credit for the period is the tax payable on the current period\u2019s taxable income, based on the applicable income tax rate for each jurisdiction, adjusted by changes in deferred tax assets and liabilities attributable to temporary differences and to unused tax losses.The current income tax charge (if applicable) is calculated on the basis of the tax laws enacted or substantively enacted at the end of the reporting period in the countries where the group companies operate and generate taxable income. Management periodically evaluates positions taken in tax returns with respect to situations in which applicable tax regulation is subject to interpretation and considers whether it is probable that a taxation authority will accept an uncertain tax treatment. The Company measures its tax balances either based on the most likely amount or the expected value, depending on which method provides a better prediction of the resolution of the uncertainty.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__36": { "value": "Deferred income tax is provided in full, using the liability method, on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the consolidated financial statements. Deferred income tax is determined using tax rates (and laws) that have been enacted or substantively enacted by the end of the reporting period and are expected to apply when the related deferred income tax asset is realized, or the deferred income tax liability is settled. Deferred tax assets are recognized only if it is probable that future taxable amounts will be available to utilize those temporary differences and losses. Current and deferred tax is recognized in profit or loss, except to the extent that it relates to items recognized in other comprehensive income or directly in equity. In this case, the tax is also recognized in other comprehensive income or directly in equity, respectively.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__37": { "value": "Intangible assetsResearch and developmentDevelopment costs that are directly attributable to the design and testing of identifiable and unique products controlled by the Company are recognized as intangible assets where the following criteria are met: \u2022 it is technically feasible to complete the product or system so that it will be available for use;\u2022 management intends to complete the product or system and use or sell it;\u2022 there is an ability to use or sell the product or system;\u2022 it can be demonstrated how the product or system will generate probable future economic benefits;\u2022 adequate technical, financial and other resources to complete the development and to use or sell the product or system are available; and\u2022 the expenditure attributable to the product or system during its development can be reliably measured.Directly attributable costs that are capitalized as part of the product include amongst others payroll costs and other costs related to creating or improving the existing product portfolio in the development phase.Capitalized development costs are recorded as intangible assets and amortized in 5 years from the point at which the asset is ready for use. Other development expenditures that do not meet these criteria are recognized as an expense as incurred. Development costs previously recognized as an expense are not recognized as an asset in a subsequent period. Expenditure on research activities is recognized as expense in the period in which it is incurred.Concessions, licenses and rights to intellectual property Concessions, licenses and rights to intellectual property are capitalized at historical cost. They have a finite useful life and are subsequently carried at cost less accumulated amortization and impairment losses. These assets are amortized over a period of 10 years.SoftwareSoftware are capitalized at historical cost and amortized on a straight-line basis over the estimated useful life of the assets, typically 3 years. Cost associated with maintaining software programs are recognized as an expense as incurred.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__39": { "value": "Property, plant and equipmentAll property, plant and equipment is stated at historical cost less depreciation. Historical cost includes expenditure that is directly attributable to the acquisition of the items. Subsequent costs are included in the asset\u2019s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of any component accounted for as a separate asset is derecognized when replaced. All other repairs and maintenance are charged to profit or loss during the reporting period in which they are incurred.Depreciation on assets is calculated by recognizing the difference between historical cost and the estimated residual values using the straight-line method over their estimated useful life in profit or loss.The estimated useful lives of property, plant and equipment for current and comparable periods are as follows: Buildings 10 - 30 yearsMachinery and equipment 5 - 10 years Right-of-use assets 1 - 9 years Pilot equipment 5 years The assets\u2019 residual values and useful lives are reviewed, and adjusted if appropriate, at the end of each reporting period. The costs of future replacement are capitalized based on the component approach. Under this approach the total costs are allocated to the \u2018component assets\u2019. Government grants on investments, if applicable, are deducted from the purchase price or manufacturing price of the assets to which the government grants relate.An asset\u2019s carrying amount is written down immediately to its recoverable amount if the asset\u2019s carrying amount is greater than its estimated recoverable amount.Gains and losses on disposals are determined by comparing proceeds with the carrying amount and are recognized within the consolidated statement of comprehensive income.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__38": { "value": "Property, plant and equipmentAll property, plant and equipment is stated at historical cost less depreciation. Historical cost includes expenditure that is directly attributable to the acquisition of the items. Subsequent costs are included in the asset\u2019s carrying amount or recognized as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. The carrying amount of any component accounted for as a separate asset is derecognized when replaced. All other repairs and maintenance are charged to profit or loss during the reporting period in which they are incurred.Depreciation on assets is calculated by recognizing the difference between historical cost and the estimated residual values using the straight-line method over their estimated useful life in profit or loss.The estimated useful lives of property, plant and equipment for current and comparable periods are as follows: Buildings 10 - 30 yearsMachinery and equipment 5 - 10 years Right-of-use assets 1 - 9 years Pilot equipment 5 years The assets\u2019 residual values and useful lives are reviewed, and adjusted if appropriate, at the end of each reporting period. The costs of future replacement are capitalized based on the component approach. Under this approach the total costs are allocated to the \u2018component assets\u2019. Government grants on investments, if applicable, are deducted from the purchase price or manufacturing price of the assets to which the government grants relate.An asset\u2019s carrying amount is written down immediately to its recoverable amount if the asset\u2019s carrying amount is greater than its estimated recoverable amount", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForDepreciationExpenseExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__40": { "value": "Leases As a lesseeAt the inception of an agreement, the Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. To assess whether a contract conveys the right to control the use of an identified asset, the Company uses the definition of a lease in IFRS 16.The Company, as a lessee, recognizes a right-of-use asset representing its right to use the underlying asset and a lease liability representing its obligation to make lease payments at the lease commencement date.The Company elected to apply the recognition exemption for both short-term and low value leases \u2013 e.g. office equipment. As such, the Company recognizes lease payments associated with these leases as an expense on a straight-line basis over the lease term.The right-of-use asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle and remove the underlying asset or to restore the underlying asset or the site on which it is located, less any lease incentives received.The right-of-use asset is subsequently depreciated using the straight-line method from the commencement date to the end of the lease term, unless the lease transfers ownership of the underlying asset to the Company by the end of the lease term or the cost of the right-of-use asset reflects that the Company will exercise a purchase option. In that case the right-of-use asset will be depreciated over the useful life of the underlying asset, which is determined on the same basis as those of property, plant and equipment. In addition, the right-of- use asset is periodically reduced by impairment losses, if any, and adjusted for certain remeasurements of the lease liability.The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company\u2019s incremental borrowing rate. Subsequently, the lease liability is increased by the interest costs on the lease liability and decreased by lease payments made.Lease payments included in the measurement of the lease liability comprise the following:\u2022 fixed payments, including in-substance fixed payments;\u2022 variable lease payments that depend on an index or a rate, initially measured using the index or rate as at the commencement date;\u2022 amounts expected to be payable under a residual value guarantee; and\u2022 the exercise price under a purchase option that the Company is reasonably certain to exercise, lease payments in an optional renewal period if the Company is reasonably certain to exercise an extension option, and penalties for early termination of a lease unless the Company is reasonably certain not to terminate early.The lease liability is measured at amortized cost using the effective interest method. The lease liability is remeasured when there is a change in future lease payments arising from a change in index or rate, a change in the estimate of the amount expected to be payable under a residual value guarantee, or as appropriate, changes in the assessment whether a purchase or renewal option is reasonably certain to be exercised or a termination option is reasonably certain not to be exercised.When the lease liability is remeasured as abovementioned, a corresponding adjustment is made to the carrying amount of the right-of-use asset or is recorded in profit or loss if the carrying amount of the right-of-use asset has been reduced to zero.The Company\u2019s right-of-use assets and lease liabilities are presented under Property, plant and equipment and Lease liabilities, respectively.As a lessorLeases in which the Company does not transfer substantially all the risks and rewards incidental to ownership of an asset are classified as operating leases. The Company has rental income from the lease of pilot equipment. This rental income is accounted for on a straight-line basis over the lease terms and is included in gross income in the statement of comprehensive income. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognized over the lease term on the same basis as rental income. Contingent rents are recognized as gross income in the period in which they are earned.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__42": { "value": "Impairment of non-financial assets Non-financial assets with a definite useful life are tested for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognized for the amount by which the asset\u2019s carrying amount exceeds its recoverable amount. The recoverable amount is the higher of an asset\u2019s fair value less costs of disposal and value in use. For the purposes of assessing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash inflows which are largely independent of the cash inflows from other assets or groups of assets (cash-generating units). Non-financial assets that suffered an impairment are reviewed for possible reversal of the impairment at the end of each reporting period.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__41": { "value": "Impairment of non-financial assets Non-financial assets with a definite useful life are tested for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognized for the amount by which the asset\u2019s carrying amount exceeds its recoverable amount. The recoverable amount is the higher of an asset\u2019s fair value less costs of disposal and value in use. For the purposes of assessing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash inflows which are largely independent of the cash inflows from other assets or groups of assets (cash-generating units). Non-financial assets that suffered an impairment are reviewed for possible reversal of the impairment at the end of each reporting period.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__43": { "value": "Inventories Inventories mainly relate to raw materials, semi-finished goods, work in progress and finished goods and are valued at the lower of cost and net realizable value. Cost comprises direct materials, direct labour and an appropriate proportion of variable and fixed overhead expenditure, the latter being allocated on the basis of normal operating capacity. Costs of purchased inventory are determined after deducting rebates and discounts. Costs are determined using the first in first out method. Net realizable value is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__45": { "value": "Financial assets \u2013 Classification and measurementThe Company classifies its financial assets in the following measurement categories:\u2022 those to be measured subsequently at fair value (either through other comprehensive Income (OCI) or through profit or loss), and\u2022 those to be measured at amortized cost.The classification depends on the entity\u2019s business model for managing the financial assets and the contractual terms of the cash flows.Financial assets - Recognition and derecognitionRegular purchases and sales of financial assets are recognized on the trade-date, the date on which the Company commits to purchase or sell the asset. Financial assets are derecognized when the rights to receive cash flows from the financial assets have expired or have been transferred and the Company has transferred substantially all the risks and rewards of ownership.Financial assets \u2013 Initial recognitionAt initial recognition the Company measures a financial asset at its fair value. Except for cash and cash equivalents, the initial measurement of a financial asset is adjusted for directly attributable transaction cost. Transaction costs of financial assets carried at fair value through profit or loss (cash and cash equivalents) are expensed in profit or loss.Financial assets \u2013 Subsequent MeasurementsSubsequent measurement depends on the Company\u2019s business model for managing the asset and the cash flow characteristics of the asset. There are three measurement categories into which the Company classifies its debt instruments: (i) Amortized cost, (ii) Fair value through profit or loss; and (iii) Fair value through other comprehensive income.The Company makes no use of derivative financial instruments. Besides cash and cash equivalents that are measured at fair value through profit or loss, the Company\u2019s receivables are measured at amortized costs. Interest income (if any) from these financial assets is included in finance income using the effective interest rate method. Any gain or loss arising on derecognition is recognized directly in profit or loss.Financial assets \u2013 ImpairmentThe Company assesses on a forward-looking basis the expected credit losses associated with its financial instruments carried at amortized cost. The impairment methodology applied depends on whether there has been a significant increase in credit risk. The Company has no trade receivables nor amounts due from customers for contract work including a significant finance component and is therefore allowed to apply the simplified approach under IFRS 9, in which the credit losses are measured using a lifetime expected loss allowance for all trade receivables.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__44": { "value": "Financial assets \u2013 Classification and measurementThe Company classifies its financial assets in the following measurement categories:\u2022 those to be measured subsequently at fair value (either through other comprehensive Income (OCI) or through profit or loss), and\u2022 those to be measured at amortized cost.The classification depends on the entity\u2019s business model for managing the financial assets and the contractual terms of the cash flows.Financial assets - Recognition and derecognitionRegular purchases and sales of financial assets are recognized on the trade-date, the date on which the Company commits to purchase or sell the asset. Financial assets are derecognized when the rights to receive cash flows from the financial assets have expired or have been transferred and the Company has transferred substantially all the risks and rewards of ownership.Financial assets \u2013 Initial recognitionAt initial recognition the Company measures a financial asset at its fair value. Except for cash and cash equivalents, the initial measurement of a financial asset is adjusted for directly attributable transaction cost. Transaction costs of financial assets carried at fair value through profit or loss (cash and cash equivalents) are expensed in profit or loss.Financial assets \u2013 Subsequent MeasurementsSubsequent measurement depends on the Company\u2019s business model for managing the asset and the cash flow characteristics of the asset. There are three measurement categories into which the Company classifies its debt instruments: (i) Amortized cost, (ii) Fair value through profit or loss; and (iii) Fair value through other comprehensive income.The Company makes no use of derivative financial instruments. Besides cash and cash equivalents that are measured at fair value through profit or loss, the Company\u2019s receivables are measured at amortized costs. Interest income (if any) from these financial assets is included in finance income using the effective interest rate method. Any gain or loss arising on derecognition is recognized directly in profit or loss.Financial assets \u2013 ImpairmentThe Company assesses on a forward-looking basis the expected credit losses associated with its financial instruments carried at amortized cost. The impairment methodology applied depends on whether there has been a significant increase in credit risk. The Company has no trade receivables nor amounts due from customers for contract work including a significant finance component and is therefore allowed to apply the simplified approach under IFRS 9, in which the credit losses are measured using a lifetime expected loss allowance for all trade receivables. Financial liabilities - Recognition and measurementFinancial liabilities are recognized when the Company becomes a party to the contractual provisions of the financial instrument. The Company only has financial liabilities at amortized cost and makes no use of derivative financial instruments.Financial liabilities at amortized costsFinancial liabilities at amortized cost include trade and other payables. Trade and other payables are initially recognized at fair value equaling the amount required to be paid, less, when material, a discount to reduce the payables to fair value. Subsequently, trade and other payables are measured at amortized cost using the effective interest method. Trade and other payables are classified as current liabilities due to their short-term nature, except for maturities greater than 12 months after the end of the reporting period. These are classified as non-current liabilities.Financial liabilities \u2013 DerecognitionThe Company derecognizes a financial liability when its contractual obligations are discharged or cancelled or expire. On derecognition of a financial liability, the difference between the carrying amount extinguished and the consideration paid (including any non-cash assets transferred or liabilities assumed) is recognized in the consolidated statement of comprehensive income.The Company also derecognizes a financial liability when its terms are modified and the cash flows of the modified liability are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. However, when the cash flows of the modified liability are not substantially different, the Company (i) recalculates the amortized cost of the modified financial liability by discounting the modified contractual cash flows using the original effective interest rate and (ii) recognizes any adjustment in the consolidated statement of comprehensive income.Offsetting financial instrumentsFinancial assets and liabilities are offset and the net amount reported in the balance sheet when there is a legally enforceable right to offset the recognized amounts and there is an intention to settle on a net basis or realize the asset and settle the liability simultaneously. The Company does not have any legally enforceable right to offset the recognized amounts in the balance sheet.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__46": { "value": "Financial assets \u2013 ImpairmentThe Company assesses on a forward-looking basis the expected credit losses associated with its financial instruments carried at amortized cost. The impairment methodology applied depends on whether there has been a significant increase in credit risk. The Company has no trade receivables nor amounts due from customers for contract work including a significant finance component and is therefore allowed to apply the simplified approach under IFRS 9, in which the credit losses are measured using a lifetime expected loss allowance for all trade receivables.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__47": { "value": "Financial liabilities - Recognition and measurementFinancial liabilities are recognized when the Company becomes a party to the contractual provisions of the financial instrument. The Company only has financial liabilities at amortized cost and makes no use of derivative financial instruments.Financial liabilities at amortized costsFinancial liabilities at amortized cost include trade and other payables. Trade and other payables are initially recognized at fair value equaling the amount required to be paid, less, when material, a discount to reduce the payables to fair value. Subsequently, trade and other payables are measured at amortized cost using the effective interest method. Trade and other payables are classified as current liabilities due to their short-term nature, except for maturities greater than 12 months after the end of the reporting period. These are classified as non-current liabilities.Financial liabilities \u2013 DerecognitionThe Company derecognizes a financial liability when its contractual obligations are discharged or cancelled or expire. On derecognition of a financial liability, the difference between the carrying amount extinguished and the consideration paid (including any non-cash assets transferred or liabilities assumed) is recognized in the consolidated statement of comprehensive income.The Company also derecognizes a financial liability when its terms are modified and the cash flows of the modified liability are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. However, when the cash flows of the modified liability are not substantially different, the Company (i) recalculates the amortized cost of the modified financial liability by discounting the modified contractual cash flows using the original effective interest rate and (ii) recognizes any adjustment in the consolidated statement of comprehensive income.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__48": { "value": "Financial liabilities \u2013 DerecognitionThe Company derecognizes a financial liability when its contractual obligations are discharged or cancelled or expire. On derecognition of a financial liability, the difference between the carrying amount extinguished and the consideration paid (including any non-cash assets transferred or liabilities assumed) is recognized in the consolidated statement of comprehensive income.The Company also derecognizes a financial liability when its terms are modified and the cash flows of the modified liability are substantially different, in which case a new financial liability based on the modified terms is recognized at fair value. However, when the cash flows of the modified liability are not substantially different, the Company (i) recalculates the amortized cost of the modified financial liability by discounting the modified contractual cash flows using the original effective interest rate and (ii) recognizes any adjustment in the consolidated statement of comprehensive income.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForDerecognitionOfFinancialInstrumentsExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__49": { "value": "Offsetting financial instrumentsFinancial assets and liabilities are offset and the net amount reported in the balance sheet when there is a legally enforceable right to offset the recognized amounts and there is an intention to settle on a net basis or realize the asset and settle the liability simultaneously. The Company does not have any legally enforceable right to offset the recognized amounts in the balance sheet.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForOffsettingOfFinancialInstrumentsExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__50": { "value": "Trade and other receivables Trade and other receivables are amounts due from customers for products delivered and services performed in the ordinary course of business. If collection is expected in one year or less, they are classified as current assets. If not, they are presented as non-current assets. Trade receivables are generally due for settlement immediately and therefore all classified as current assets.Trade receivables are recognized initially at their transaction price, the amount of consideration that is unconditional, unless they contain significant financing components when they are recognized at fair value. They are subsequently measured at amortized cost using the effective interest method, less loss allowance.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__51": { "value": "Cash and cash equivalents For the purpose of presentation in the statement of cash flows, cash and cash equivalents includes cash on hand, deposits held at call with financial institutions, other short-term, highly liquid investments with original maturities of three months or less that are readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value. Cash and cash equivalents are measured at fair value.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__52": { "value": "Share capital \u2013 Ordinary sharesAn ordinary share entitles its owner to a voting right and, only to extent so ultimately decided by the general meeting of the Company (the General Meeting), to dividends. ", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__53": { "value": "Trade and other payables These amounts represent liabilities provided to the Company prior to the end of the financial year which are unpaid. Trade and other payables are presented as current liabilities unless payment is not due within 12 months after the reporting period. They are recognized initially at their fair value. And subsequent measurement at amortized cost using the effective interest method.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherPayablesExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__54": { "value": "Cash flow statement The cash flow statement has been prepared using the indirect method, whereby profit or loss is adjusted for the effects of transactions of a non-cash nature, any deferrals or accruals of past or future operating cash receipts or payments, and items of income or expense associated with investing or financing cash flows.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForCashFlowsExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__55": { "value": "Segment reportingThe Company is engaged in the business of developing, producing and selling hollow fiber membrane modules. NX Filtration sells its filtration membranes in the form of modules in its two business lines: Clean Municipal Water and Sustainable Industrial Water. As there is a strong interrelationship between NX Filtration\u2019s activities and these business lines, management reviews the profitability and monitors the performance of the two business lines, despite the split in revenue, solely on an aggregated basis for resource allocation and overall performance measurement. All financial segment information can therefore be found in the consolidated financial statements.", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__56": { "value": "Financial instruments and 3risk managementFinancial Instrument classificationAs result of regular business practices, the Company holds positions in a variety of financial instruments. The financial instruments are presented in the balance sheet and consists of cash and cash equivalents, trade receivables and other receivables, trade payables and other payables.The Company does not use foreign exchange contracts and/or foreign exchange options and does not deal with such financial derivatives. On each balance date, financial instruments are reviewed to see whether or not an objective indication exists for the impairment of a financial asset or a group of financial assets.If an objective indication for impairment exists, the Company determines the amount of impairment losses and charges this amount to the consolidated statement of comprehensive income. As a result of the use of financial instruments, the Company incurs credit risks, liquidity risks and market risks.Risk managementThe Management Board has the overall responsibility for the establishment and oversight of the Group\u2019s risk management framework. The Group\u2019s risk management policies are established to identify and analyze the risks faced by the Group, to set appropriate risk limits and controls and to monitor risks and adherence to limits. Risk management policies and systems are reviewed regularly to reflect changes in market conditions. Credit riskCredit risk is the risk of a financial loss in case a customer does not comply with the contractual obligations. Credit risks are mainly incurred from receivables from customers. The Company executes a strict policy to minimize credit risks. To control these risks, the Company makes use of information from licensed credit agencies. If necessary, credit risks will be mitigated by the use of credit insurances, bank guarantees, prepayments and other insurances. Cash- and cash equivalents are placed by a number of banks. The Company determines the credit risk of cash- and cash equivalents that are placed with these banks, by solely doing business with highly respectable banks. The Company evaluates the concentration risk with respect to trade receivables as medium. For the financial year 2023, one customer accounted for approximately 12% (2022: 19%) of the revenue of the sale of goods.Expected credit losses The Company has the following types of financial assets that are subject to the expected credit loss model:\u2022 Trade and other receivablesThe Company applies the IFRS 9 simplified approach to measuring expected credit losses which uses a lifetime expected loss allowance for all trade and other receivables.To measure the expected credit losses, trade and other receivables have been grouped based on shared credit risk characteristics and the days past due. The expected loss rates used at 31 December 2023 and 31 December 2022 are based on the payment profiles of sales over a period of 12 months of the preceding financial year and the corresponding historical credit losses experienced related to these sales. The historical loss rates are adjusted to reflect current and forward-looking information based on macro-economic factors affecting the ability of the customers to settle the receivables. The Company retrieves the latter from externally available information from credit rating agencies. Credit insured amounts are excluded from the determination of the loss allowance.On that basis, the loss allowance as of 31 December 2023 and 31 December 2022 was determined as follows for both trade and other receivables:In EUR \u2018000 31 December 2023 Current Overdue Overdue Overdue Overdue > amount < 30 days 31 - 60 days 61 - 90 days 90 days Expected loss rate 0% 0% 0% 0% 2%Gross carrying amount - trade receivables and other receivables 6,864 35 50 4 2,147 Loss allowance - - - - 42 In EUR \u2018000 31 December 2022 Current Overdue Overdue Overdue Overdue > amount < 30 days 31 - 60 days 61 - 90 days 90 days Expected loss rate 0% 0% 0% 0% 38%Gross carrying amount - trade receivables and other receivables 6,824 108 17 137 110 Loss allowance - - - - 42 Trade and other receivables are written off when there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, amongst others, the failure of a debtor to engage in a repayment plan with the Company and a failure to make contractual payments. We are in close consultation with our customers regarding the overdue invoices and don\u2019t foresee any significant losses.Impairment losses on trade and other receivables are recognized in the consolidated statement of comprehensive income as a separate line item. Subsequent recoveries of amounts previously written off are credited against the same line item. Liquidity risk Liquidity risk is the risk that the Company will not be able to meet its financial obligations. The Company\u2019s approach to managing liquidity is to ensure that, as far as possible, it will always have sufficient liquidity to meet its obligations when they become due, avoiding unacceptable losses or damages to the Company\u2019s reputation. The Company monitors its liquidity risk on an ongoing basis. In June 2021, NX Filtration became a publicly traded company when it listed its ordinary shares on Euronext Amsterdam, raising \u20ac165 million for inter alia the acceleration of its business plan. This provided the necessary funds for amongst others investing in pilot systems, expanding the organization, expanding the production capacity and supporting its innovation agenda. As per 31 December 2023, the Company has \u20ac50 million cash available.The tables below analyses the Company\u2019s financial liabilities on their contractual maturities for all non- derivative financial liabilities for which the contractual maturities are essential for an understanding of the timing of the cash flows.Note that the interest component of the lease liabilities in the table below reflects the undiscounted value of the future lease payments.In EUR \u2018000 31 December 2023 Less than 3 months Between 1 Over 3 months to 1 year and 5 years 5 years TotalTrade and other payables 15,006 68 - - 15,074 Lease liabilities 140 422 951 - 1,513 Lease liabilities - Interest component 17 44 82 - 143 Total non-derivatives 15,163 534 1,033 - 16,730 In EUR \u2018000 31 December 2022 Less than 3 months Between 1 Over 3 months to 1 year and 5 years 5 years TotalTrade and other payables 4,988 - - - 4,988 Lease liabilities 121 376 1,310 1 1,808 Lease liabilities - Interest component 17 44 82 - 143 Total non-derivatives 5,126 420 1,392 1 6,939Market risk Foreign exchange riskThe Company does predominately business in the euro currency. Therefore, the currency risk is limited and largely concerns positions and (future) transactions in euros. Management has determined, based on a risk assessment, that these currency risks do not need to be hedged. The Company\u2019s exposure to other foreign exchange movements is not significant and therefore no sensitivity analysis is included. The concentration risk is therefore considered low.Price risk The Company incurs price risks on the purchase of (raw) materials for the difference between the market price at the time of the purchase and during the actual performance. Price risk is currently managed by agreeing on (long term) framework agreements with its suppliers. With the expected growing volume of purchase, the Company expects to be able to negotiate lower prices for raw materials. In case the costs of raw materials and consumables increase with 2%, the impact on profit before tax is \u20ac59 thousand.Interest risk The Company is exposed to interest rate risk and cash flow risk on its current accounts. If interest rates on its cash and cash equivalent balances would increase by 0.5%, the impact on profit before tax is \u20ac0.3 million.", "dimensions": { "concept": "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__57": { "value": "Financial Instrument classificationAs result of regular business practices, the Company holds positions in a variety of financial instruments. The financial instruments are presented in the balance sheet and consists of cash and cash equivalents, trade receivables and other receivables, trade payables and other payables.The Company does not use foreign exchange contracts and/or foreign exchange options and does not deal with such financial derivatives. On each balance date, financial instruments are reviewed to see whether or not an objective indication exists for the impairment of a financial asset or a group of financial assets.If an objective indication for impairment exists, the Company determines the amount of impairment losses and charges this amount to the consolidated statement of comprehensive income. As a result of the use of financial instruments, the Company incurs credit risks, liquidity risks and market risks.", "dimensions": { "concept": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__58": { "value": "Credit riskCredit risk is the risk of a financial loss in case a customer does not comply with the contractual obligations. Credit risks are mainly incurred from receivables from customers. The Company executes a strict policy to minimize credit risks. To control these risks, the Company makes use of information from licensed credit agencies. If necessary, credit risks will be mitigated by the use of credit insurances, bank guarantees, prepayments and other insurances. Cash- and cash equivalents are placed by a number of banks. The Company determines the credit risk of cash- and cash equivalents that are placed with these banks, by solely doing business with highly respectable banks. The Company evaluates the concentration risk with respect to trade receivables as medium. For the financial year 2023, one customer accounted for approximately 12% (2022: 19%) of the revenue of the sale of goods.Expected credit losses The Company has the following types of financial assets that are subject to the expected credit loss model:\u2022 Trade and other receivablesThe Company applies the IFRS 9 simplified approach to measuring expected credit losses which uses a lifetime expected loss allowance for all trade and other receivables.To measure the expected credit losses, trade and other receivables have been grouped based on shared credit risk characteristics and the days past due. The expected loss rates used at 31 December 2023 and 31 December 2022 are based on the payment profiles of sales over a period of 12 months of the preceding financial year and the corresponding historical credit losses experienced related to these sales. The historical loss rates are adjusted to reflect current and forward-looking information based on macro-economic factors affecting the ability of the customers to settle the receivables. The Company retrieves the latter from externally available information from credit rating agencies. Credit insured amounts are excluded from the determination of the loss allowance.On that basis, the loss allowance as of 31 December 2023 and 31 December 2022 was determined as follows for both trade and other receivables:In EUR \u2018000 31 December 2023 Current Overdue Overdue Overdue Overdue > amount < 30 days 31 - 60 days 61 - 90 days 90 days Expected loss rate 0% 0% 0% 0% 2%Gross carrying amount - trade receivables and other receivables 6,864 35 50 4 2,147 Loss allowance - - - - 42 In EUR \u2018000 31 December 2022 Current Overdue Overdue Overdue Overdue > amount < 30 days 31 - 60 days 61 - 90 days 90 days Expected loss rate 0% 0% 0% 0% 38%Gross carrying amount - trade receivables and other receivables 6,824 108 17 137 110 Loss allowance - - - - 42 Trade and other receivables are written off when there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, amongst others, the failure of a debtor to engage in a repayment plan with the Company and a failure to make contractual payments. We are in close consultation with our customers regarding the overdue invoices and don\u2019t foresee any significant losses.Impairment losses on trade and other receivables are recognized in the consolidated statement of comprehensive income as a separate line item. Subsequent recoveries of amounts previously written off are credited against the same line item.", "dimensions": { "concept": "ifrs-full:DisclosureOfCreditRiskExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__59": { "value": "Expected credit losses The Company has the following types of financial assets that are subject to the expected credit loss model:\u2022 Trade and other receivablesThe Company applies the IFRS 9 simplified approach to measuring expected credit losses which uses a lifetime expected loss allowance for all trade and other receivables.To measure the expected credit losses, trade and other receivables have been grouped based on shared credit risk characteristics and the days past due. The expected loss rates used at 31 December 2023 and 31 December 2022 are based on the payment profiles of sales over a period of 12 months of the preceding financial year and the corresponding historical credit losses experienced related to these sales. The historical loss rates are adjusted to reflect current and forward-looking information based on macro-economic factors affecting the ability of the customers to settle the receivables. The Company retrieves the latter from externally available information from credit rating agencies. Credit insured amounts are excluded from the determination of the loss allowance.On that basis, the loss allowance as of 31 December 2023 and 31 December 2022 was determined as follows for both trade and other receivables:In EUR \u2018000 31 December 2023 Current Overdue Overdue Overdue Overdue > amount < 30 days 31 - 60 days 61 - 90 days 90 days Expected loss rate 0% 0% 0% 0% 2%Gross carrying amount - trade receivables and other receivables 6,864 35 50 4 2,147 Loss allowance - - - - 42 In EUR \u2018000 31 December 2022 Current Overdue Overdue Overdue Overdue > amount < 30 days 31 - 60 days 61 - 90 days 90 days Expected loss rate 0% 0% 0% 0% 38%Gross carrying amount - trade receivables and other receivables 6,824 108 17 137 110 Loss allowance - - - - 42 Trade and other receivables are written off when there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, amongst others, the failure of a debtor to engage in a repayment plan with the Company and a failure to make contractual payments. We are in close consultation with our customers regarding the overdue invoices and don\u2019t foresee any significant losses.Impairment losses on trade and other receivables are recognized in the consolidated statement of comprehensive income as a separate line item. Subsequent recoveries of amounts previously written off are credited against the same line item.", "dimensions": { "concept": "ifrs-full:DisclosureOfAllowanceForCreditLossesExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__61": { "value": "Market risk Foreign exchange riskThe Company does predominately business in the euro currency. Therefore, the currency risk is limited and largely concerns positions and (future) transactions in euros. Management has determined, based on a risk assessment, that these currency risks do not need to be hedged. The Company\u2019s exposure to other foreign exchange movements is not significant and therefore no sensitivity analysis is included. The concentration risk is therefore considered low.Price risk The Company incurs price risks on the purchase of (raw) materials for the difference between the market price at the time of the purchase and during the actual performance. Price risk is currently managed by agreeing on (long term) framework agreements with its suppliers. With the expected growing volume of purchase, the Company expects to be able to negotiate lower prices for raw materials. In case the costs of raw materials and consumables increase with 2%, the impact on profit before tax is \u20ac59 thousand.Interest risk The Company is exposed to interest rate risk and cash flow risk on its current accounts. If interest rates on its cash and cash equivalent balances would increase by 0.5%, the impact on profit before tax is \u20ac0.3 million.", "dimensions": { "concept": "ifrs-full:DisclosureOfMarketRiskExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__60": { "value": "Liquidity risk Liquidity risk is the risk that the Company will not be able to meet its financial obligations. The Company\u2019s approach to managing liquidity is to ensure that, as far as possible, it will always have sufficient liquidity to meet its obligations when they become due, avoiding unacceptable losses or damages to the Company\u2019s reputation. The Company monitors its liquidity risk on an ongoing basis. In June 2021, NX Filtration became a publicly traded company when it listed its ordinary shares on Euronext Amsterdam, raising \u20ac165 million for inter alia the acceleration of its business plan. This provided the necessary funds for amongst others investing in pilot systems, expanding the organization, expanding the production capacity and supporting its innovation agenda. As per 31 December 2023, the Company has \u20ac50 million cash available.The tables below analyses the Company\u2019s financial liabilities on their contractual maturities for all non- derivative financial liabilities for which the contractual maturities are essential for an understanding of the timing of the cash flows.Note that the interest component of the lease liabilities in the table below reflects the undiscounted value of the future lease payments.In EUR \u2018000 31 December 2023 Less than 3 months Between 1 Over 3 months to 1 year and 5 years 5 years TotalTrade and other payables 15,006 68 - - 15,074 Lease liabilities 140 422 951 - 1,513 Lease liabilities - Interest component 17 44 82 - 143 Total non-derivatives 15,163 534 1,033 - 16,730 In EUR \u2018000 31 December 2022 Less than 3 months Between 1 Over 3 months to 1 year and 5 years 5 years TotalTrade and other payables 4,988 - - - 4,988 Lease liabilities 121 376 1,310 1 1,808 Lease liabilities - Interest component 17 44 82 - 143 Total non-derivatives 5,126 420 1,392 1 6,939", "dimensions": { "concept": "ifrs-full:DisclosureOfLiquidityRiskExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__65": { "value": "Revenue from sale of goodsThe Company\u2019s revenue originates from sale of products. The Company recognizes all its revenue at a point in time, when control over the goods is transferred to the customer. Set out below is the disaggregation of the Company\u2019s revenue from sale of goods based on the Company\u2019s two business lines.In EUR \u2018000 2023 2022Type of markets Sustainable Industrial Water 4,625 4,977 Clean Municipal Water 2,613 2,569 Total revenues from sale of goods 7,238 7,546", "dimensions": { "concept": "ifrs-full:DisclosureOfRevenueExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__67": { "value": "Other income Set out below is the disaggregation of the Company\u2019s other income.In EUR \u2018000 2023 2022Government grants 174 338 Pilot income 641 400 Other 0 70 Total other income 815 808 Government grants comprises of the several government grants received for the Company\u2019s research & development activities in the field of water filtration. NX Filtration has fulfilled all conditions relating to government grants at time of recognition. Pilot income relates to rental income from pilot equipment.", "dimensions": { "concept": "ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__66": { "value": "Other income Set out below is the disaggregation of the Company\u2019s other income.In EUR \u2018000 2023 2022Government grants 174 338 Pilot income 641 400 Other 0 70 Total other income 815 808 Government grants comprises of the several government grants received for the Company\u2019s research & development activities in the field of water filtration. NX Filtration has fulfilled all conditions relating to government grants at time of recognition. Pilot income relates to rental income from pilot equipment.", "dimensions": { "concept": "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__68": { "value": "Government grants comprises of the several government grants received for the Company\u2019s research & development activities in the field of water filtration. NX Filtration has fulfilled all conditions relating to government grants at time of recognition", "dimensions": { "concept": "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__69": { "value": "Personnel expensesIn EUR \u2018000 2023 2022Salaries and wages 11,423 7,937 Social security contributions 1,457 716 Pension contributions 359 222 External personnel cost 497 578 Capitalised personnel expenses (868) (1,090)Total personnel expenses 12,868 8,363 Capitalised personnel expenses relate for \u20ac184 thousand to development costs (intangible assets) and \u20ac684 thousand to property plant & equipment (2022 mainly relates to development costs).The number of FTEs per year-end are: 2023 2022Direct employees 67 52 Indirect employees 99 83 Total FTE 166 135 A total of 24 (2022:18) employees are employed outside the Netherlands. This includes 12 employees which are hired through an external human resource service provider (2022: 15). The average number of FTEs during 2023 was 159 (2022: 110). Pensions The Company has a defined contribution scheme for certain key employees, in which the pension contribution is predetermined and based on the gross salary and the age of the individual employee. Furthermore, the Company has a defined contribution scheme for the other employees, in which the pension contribution is predetermined and based on the gross salary only. Both schemes limit the Group\u2019s legal obligation to the amount it agrees to contribute during the period of employment. The assets of the plans are held separately from those of the Company in funds under the control of pension insurance companies.The average annual net premium contribution for 2023 is 4.0% (2022: 3.8%). The pension contributions are paid on a monthly basis to the pension fund. The net contribution for 2023 amounts to \u20ac359 thousand (\u20ac222 thousand in 2022). The premium payable during the financial year is charged to the consolidated statement of comprehensive income and is classified as costs of personnel.Aside from premium payables, the Company does not have any additional obligations in respect to the pension schemes", "dimensions": { "concept": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__62": { "value": "Capital managementThe Company\u2019s objectives when managing capital is to safeguard the Company\u2019s ability to continue as a going concern and maintain an optimal capital structure to reduce the cost of capital. The table below provides an analysis of net debt and the movements in net debt for each of the periods presented. Cash and cash Lease Net In EUR \u2018000 equivalents liabilities debt At 1 January 2022: 133,433 (1,394) 132,039 Cash flows (29,159) - (29,159)New leases - (655) (655)Other changes - 241 241 Net debt - 31 December 2022 104,274 (1,808) 102,466 Cash flows (54,346) - (54,346)New leases - (240) (240)Other changes - 535 535 Net debt - 31 December 2023 49,928 (1,513) 48,415 Other changes comprises a cash movement van \u20ac600 thousand and a negative non-cash movement of \u20ac65 thousand which relates to effective interest accounting on lease liabilities.", "dimensions": { "concept": "ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__63": { "value": "Fair value estimationAt 31 December 2023 and 31 December 2022, the Company\u2019s cash and cash equivalents are measured at fair value. The carrying amounts of trade and other receivables and trade and other payables approximated their fair values due to the short-term maturities of these assets and liabilities.Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. IFRS establishes a three tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).", "dimensions": { "concept": "ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__64": { "value": "Critical accounting estimates and judgementsThe preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reported periods.The estimates and associated assumptions are based on historical experiences and various other factors that are believed to be reasonable under the circumstances. Actual results may differ from these estimates.Development costs The capitalized development costs are based on management judgements taken into account:\u2022 the technical feasibility to complete the product or system so that it will be available for use;\u2022 management intends to complete the product or system and use or sell it;\u2022 the ability to use or sell the product or system;\u2022 the availability of adequate technical, financial and other resources to complete the development.In determining the development costs to be capitalized, the Company estimates the expected future economic benefits of the respective product or system that is the result of a development project. Furthermore, management estimates the useful life of such product or system (note 2).Deferred tax assetsDeferred tax assets are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, unused tax losses and unused tax credits. Deferred tax assets are recognized only to the extent that it is probable that sufficient taxable profit will be available against which those unused tax losses, unused tax credits or deductible temporary differences can be utilised. This assessment requires significant management judgements and assumptions and is inherently uncertain.", "dimensions": { "concept": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__70": { "value": "The number of FTEs per year-end are: 2023 2022Direct employees 67 52 Indirect employees 99 83 Total FTE 166 135 A total of 24 (2022:18) employees are employed outside the Netherlands", "dimensions": { "concept": "ifrs-full:DisclosureOfInformationAboutEmployeesExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__71": { "value": "Operating costs The operating costs can be divided into the following cost categories:In EUR \u2018000 2023 2022Housing expenses 1,534 998 Other personnel expenses 1,006 1,077 Administrative expenses 1,888 1,277 Selling expenses 1,699 1,450 Operating expenses 1,141 800 Total operating costs 7,268 5,602 In 2023 additional costs were mainly made for IT and software improvements, energy consumption, advisory, consultancy and rental/warehouse costs to accommodate the increase in inventory.", "dimensions": { "concept": "ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__72": { "value": "External research & development costsIn EUR \u2018000 2023 2022Gross external R&D Costs 1,233 1,059 Capitalized external R&D costs (637) (216)Total external research & development cost (net) 596 843 Capitalised external R&D costs relate for \u20ac546 thousand to development costs (intangible assets) and for \u20ac90 thousand to property plant and equipment (2022 mainly relates to development costs).To maintain its technological leadership position, NX Filtration continuously invests in its research and development activities for further improvement of existing products and development of new products. Gross research and development costs, including R&D salaries in 2023 amounted to \u20ac4.2 million (2022: \u20ac2.5 million).Development costs that are directly attributable to the design and testing of identifiable and unique products and systems controlled by the Company are recognized as intangible assets and are capitalized as part of the product. Other research and development expenditures are recognized as an expense as incurred.NX Filtration currently relies on its commercially ready and available product ranges with proven applications. Going forward, the Company\u2019s strategy is to build further on this technology and make the technology available towards different applications and markets, which may require additional product development costs in future periods.", "dimensions": { "concept": "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__73": { "value": "Share based payments Depositary ReceiptsSince the incorporation of the Company in 2016, eligible and selected employees and directors have been provided with the opportunity to invest indirectly in ordinary shares in the capital of the Company by acquiring Depositary Receipts (\u201cDRs\u201d) issued by a foundation that is controlled by the majority shareholder. The DRs are not freely transferable and, under certain circumstances, the majority shareholder may require a participant to sell DRs to a party designated by the majority shareholder. If a participant voluntarily leaves the Company prior to the end of the vesting period, he/she is not entitled to the full fair market value. As a result, the IFRS 2 fair value will have to be allocated to the vesting tranches.The share participation arrangement is accounted for as an equity-settled share-based arrangement since the Company and its subsidiaries do not have an obligation to settle or to repurchase any DRs from the participants. Each DR issued by the foundation represents one ordinary share in the capital of the Company. The number of outstanding DRs held by employees of the Group are as follows: 2023 2022Outstanding at 1 January 3,792,094 3,792,094 Granted (purchased) during the year - - Exercised (325,626) - Outstanding shares at 31 December 3,466,468 3,792,094 As the Company\u2019s ordinary shares were not listed at the grant date, the fair value of the ordinary shares has been estimated by the Company as of each date a participant indirectly acquired shares in the Company. For accounting purposes, the fair value of an award is equal to the fair market value of the underlying ordinary shares at the grant date less the acquisition price paid by a participant for the DRs. Given that the participants have paid the estimated fair market value of the underlying shares as of each grant date, the fair value of the share-based payment awards is nil. Long-term incentive plan \u2013 Key employeesThe Management Board recognises the importance of its key employees to the future success of the Company. Therefore, on 26 May 2021, a long-term incentive plan (\u2018LTIP Key employees\u2019) was introduced for a number of designated employees within the group of the Company. The following grants, comprising of Ordinary Shares in the Company, have been made under this plan: Number of Exercise Grant date Awards granted Price1 January 2022 6,982 Nil 1 February 2022 788 Nil 1 January 2023 4,425 Nil The conditional rights to acquire existing Ordinary Shares granted will be exercisable in exchange for Ordinary Shares on the day that is four years after the grant date, on the condition that the relevant employee continues to be employed by the Company on this date (subject to certain arrangements for exceptional circumstances, such as death of the employee). Besides the aforementioned service vesting condition no other vesting conditions are applicable for the LTIP Key employees.Long-term incentive plan \u2013 Management BoardAs part of the newly introduced remuneration policy, which has been adopted by the general meeting of shareholders on 11 June 2021, a long-term incentive plan for the Management Board (\u2018LTIP Management Board\u2019) was introduced in order to increase the alignment between shareholder\u2019s interest and the interest of the Management Board. The following grants, comprising of Ordinary Shares in the Company, have been made under this plan:Grant date Number of Exercise Awards granted Price20 May 2022 8,296 Nil 7 April 2023 9,091 Nil The conditional rights to acquire existing Ordinary Shares granted will be exercisable in exchange for Ordinary Shares on the day that is three years after inception of the service and performance period, subject to continued employment as a member of the Management Board and certain non-market based performance vesting conditions.The service and performance period are starting on the 1st of January of the applicable financial year, in which the grant has been made. Besides the aforementioned service and performance vesting conditions there is one additional condition in place, which is an two year holding period for the Management Board after vesting date.Summary of changes in outstanding sharesChanges in outstanding shares for the period: LTIP Key LTIP Management employees Board1 January 2023 7,343 8,296 Granted 4,425 9,091 Forfeited (783) - Exercised - - Expired - - 31 December 2023 10,985 17,387 None of the outstanding shares related to the LTIP Key employees and LTIP Management Board are exercisable at 31 December 2023.Fair value measurementThe Company used the Black & Scholes model to determine the fair value of the share-based payments plans at grant date. The fair value of the Company\u2019s Ordinary Shares for the different plans at grant date was: Grant date Share award plan Grant date fair valueLTIP Key employees 1 January 2022 10.84 LTIP Key employees 1 February 2022 10.84 LTIP Management Board 20 May 2022 11.08 LTIP Key employees 1 January 2023 11.00 LTIP Management Board 7 April 2023 11.10 The present value for expected dividend over the vesting period for all plans is nil because the Company has currently no intention to distribute dividends in the foreseeable future in order to be able to further invest in the growth of the Company. Consequently and in conjunction with an exercise price of nil, both the expected volatility and risk-free-rate have no impact on the fair value determination at grant date.Share-based payment expensesShare-based payment expenses recognized as other operating costs in the statement of comprehensive income:In EUR \u2018000 2023 2022LTIP Key employees 13 18 LTIP Management Board 5 18 Sign-on equity incentive 188 - Total share-based payment expenses 206 36 For further information about the sign-on equity incentive we refer to note 16.", "dimensions": { "concept": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__75": { "value": "Finance income and expensesIn EUR \u2018000 2023 2022Interest expenses related to lease liabilities 65 61 Other interest (income) expenses (2,004) 228 Finance (income) expenses (1,939) 289 Interest expense related to lease liabilities is the result of application of IFRS 16. The other interest income is resulting from our cash and cash equivalents.", "dimensions": { "concept": "ifrs-full:DisclosureOfFinanceCostExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__74": { "value": "Finance income and expensesIn EUR \u2018000 2023 2022Interest expenses related to lease liabilities 65 61 Other interest (income) expenses (2,004) 228 Finance (income) expenses (1,939) 289 Interest expense related to lease liabilities is the result of application of IFRS 16. The other interest income is resulting from our cash and cash equivalents.", "dimensions": { "concept": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__76": { "value": "Income tax benefit (expense)This note provides an analysis of the Company\u2019s income tax, showing how the tax benefit or expense is affected by non-deductible items.The tax on the Company\u2019s loss before tax differs from the statutory amount that would arise using the tax rate applicable to losses of the entity. The reconciliation of the effective tax rate is as follows:In EUR \u2018000 2023 2022Deferred income tax Income tax (8,945) 3,071 Change in tax rates - 182 Total deferred tax benefit (expense) (8,945) 3,253 Total income tax benefit (expense) (8,945) 3,253 In EUR \u2018000 2023 2022Result from operations (23,292) (8,642)Total income tax (8,945) 3,253 Loss before income tax (14,347) (11,895)Tax calculated based on Dutch tax rate 25.8% 25.8%Tax effect of: Adjustments for previous years -0.2% 0.0%Non-taxable expenses -0.3% 0.0%Derecognition of deferred tax asset prior years -62.4% 0.0%Derecognition of deferred tax asset current-year -11.8% 0.0%Current-year losses for which no deferred tax asset is recognised -13.5% 0.0%Change in tax rates 0.0% 1.5%Other differences 0.0% 0.0%Effective tax rate -62.3% 27.3% The change in tax rates in 2022 is driven by change in the enacted Dutch tax rates for the fiscal years 2023 and further. The deferred tax assets resulting from carry-forward losses in the Netherlands have been fully derecognized in 2023 (see note 20).", "dimensions": { "concept": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__78": { "value": "Remuneration of the Management Board and the Supervisory BoardThe total amount of remuneration of the Managing Directors for the financial year 2023 comprised \u20ac1,108,058 (2022: \u20ac649,281). For the financial year 2023; The total amount of remuneration of Mr Jeroen Pynenburg comprised \u20ac329,440. His short-term incentive in cash amounted 2023 2022 Net loss attributable to equity holders (in EUR \u2018000) (23,292) (8,642)Outstanding number of shares for the basic earnings per share as at 1 January 50,000,000 50,000,000 Effect of issued ordinary shares 13,010 Weighted-average number of shares outstanding for the purpose of basic earnings per share 50,013,010 50,000,000 Weighted-average number of shares outstanding for the purpose of diluted earnings per share 50,013,010 50,000,000 Earnings per share Basic earnings per share (EUR) (0.47) (0.17)Diluted earnings per share (EUR) (0.47) (0.17)to \u20ac22,083. The total remuneration of Mr Michiel Staatsen comprised \u20ac198,980 (2022: \u20ac179,577). The total remuneration of Mr Erik Roesink comprised \u20ac175,225 (2022: \u20ac166,894). The total remuneration of Mr Marc Luttikhuis comprised \u20ac404,413 (2022: \u20ac302,810). His short-term incentive in cash amounted to \u20ac31,250 and the conditional award under the Long-Term Incentive Plan was \u20ac5,339. Both Mr Jeroen Pynenburg and Mr Marc Luttikhuis received a sign-on equity incentive with a value for 2023 of \u20ac104,266 respectively \u20ac83,333 which are included in the total amount of renumeration. The characteristics of this incentive are described below.In 2022, majority shareholder Infestos Holding E B.V. (an Infestos affiliate) has facilitated a sign-on equity incentive with Mr Marc Luttikhuis. For these purposes, Infestos Holding E B.V. has transferred a number of ordinary shares in the Company to the Company for no consideration, with a value of EUR 300,000. These ordinary shares have been delivered to a designated securities account and are subject to customary lock-up provisions. The lock-up of the ordinary shares under the sign-on equity incentive will be three years where 1/3 of the ordinary shares will be released each year and the leaver provisions provide for a re-delivery of the ordinary shares in case of a bad-leaver. In 2023, the Company has facilitated a sign-on equity incentive with Mr Jeroen Pynenburg and issued 25,190 ordinary shares to Stichting Bewaarneming Aandelen NX Filtration, with a value of \u20ac265,000. These ordinary shares have been delivered to a designated securities account and are subject to customary lock-up provisions. The lock-up of the ordinary shares under the sign-on equity incentive will be three years where 1/3 of the ordinary shares will be released each year and the leaver provisions provide for a re-delivery of the ordinary shares in case of a bad-leaver. The Management Board collectively holds 2,578,800 DRs (see note 12) in the share capital of the Company, of which Mr Michiel Staatsen holds 967,050 DRs and Mr Erik Roesink 1,611,750 DRs. These DRs are subject to lock-up restrictions. One-third of the DRs have been unconditionally released from the lock-up restrictions on 11 June 2022, one-third of the DRs have been unconditionally released from the lock-up restrictions on 11 June 2023, and the remaining one-third of the DRs will be unconditionally released from the lock-up restrictions on 11 June 2024, in each case on the condition that the relevant board member continues to be employed by the Company. The compensation for Ms Carolina Wielinga, chair of the Supervisory Board for the financial year 2023 amounts to \u20ac50,000 (2022: \u20ac50,000) and the compensation for Mr Benno van Dongen amounts to \u20ac30,000 (2022: \u20ac30,000). Mr Hans Slootweg is employed by Infestos Nederland and does not receive compensation for his Supervisory Board activities.", "dimensions": { "concept": "ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__77": { "value": "Earnings per share 2023 2022 Net loss attributable to equity holders (in EUR \u2018000) (23,292) (8,642)Outstanding number of shares for the basic earnings per share as at 1 January 50,000,000 50,000,000 Effect of issued ordinary shares 13,010 Weighted-average number of shares outstanding for the purpose of basic earnings per share 50,013,010 50,000,000 Weighted-average number of shares outstanding for the purpose of diluted earnings per share 50,013,010 50,000,000 Earnings per share Basic earnings per share (EUR) (0.47) (0.17)Diluted earnings per share (EUR) (0.47) (0.17)", "dimensions": { "concept": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__79": { "value": "Intangible assetsThe movement in intangible assets during the years was as follows:Concessions and rights ofIn EUR \u2018000 Development costs intellectual property Software Total At 1 January 2022 Cost 2,167 264 72 2,503 Accumulated impairments and amortisation (585) (89) - (674)Net book value 1,582 175 72 1,829 Year ended 31 December 2022 Opening net book value 1,582 175 72 1,829 Additions 912 11 92 1,015 Acquisitions - - - - Amortisation for the year (435) (28) (27) (490)Closing net book value 2,058 158 137 2,353 At 31 December 2022 Cost 3,078 275 164 3,517 Accumulated impairments and amortization (1,020) (117) (27) (1,164)Net book value 2,058 158 137 2,353 Year ended 31 December 2023 Opening net book value 2,058 158 137 2,353 Additions 730 65 167 962 Acquisitions - - - - Amortisation for the year (601) (32) (45) (678)Closing net book value 2,187 191 259 2,637 At 31 December 2023 Cost 3,808 340 332 4,480 Accumulated impairments and amortization (1,621) (149) (73) (1,843)Net book value 2,187 191 259 2,637 Development costsAdditions to intangible fixed assets relate to internal development projects for new products or systems or development projects for new features to existing products and systems.Concessions and rights of intellectual property Additions for concessions and rights of intellectual property relate to payments made to the patent office for the filing process of the Company\u2019s patents and intellectual property rights.Software Additions to software relate to externally acquired programs and software for amongst others sales, engineering and data management", "dimensions": { "concept": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__80": { "value": "property, plant and equipment during the years was as follows: Machinery and Pilot Assets underIn EUR \u2018000 Land & buildings equipment equipment construction Total At 1 January 2022 Cost 223 5,372 2,640 2,985 11,220 Accumulated impairments and depreciation - (1,853) (217) - (2,070)Net book value 223 3,519 2,423 2,985 9,150 Year ended 31 December 2022 Opening net book value 223 3,519 2,423 2,985 9,150 Additions - 513 - 11,140 11,653 Reclassification assets under construction 3,825 3,591 4,568 (11,984) - Disposal - (75) (177) - (252)Depreciation for the year (47) (1,216) (834) - (2,097)Depreciation of disposal - 58 23 - 81 Closing net book value 4,001 6,390 6,003 2,141 18,535 At 31 December 2022 Cost 4,048 9,401 7,031 2,141 22,621 Accumulated impairments and depreciation (47) (3,011) (1,028) - (4,086)Net book value 4,001 6,390 6,003 2,141 18,535 Year ended 31 December 2023 Opening net book value 4,001 6,390 6,003 2,141 18,535 Additions - - - 42,977 42,977 Reclassification assets under construction 8 884 724 (1,616) - Reclassification to inventories - - (484) - (484)Disposal - (237) - - (237)Depreciation for the year (56) (1,596) (1,474) - (3,126)Depreciation of disposal (9) 234 - - 225 Closing net book value 3,944 5,675 4,769 43,502 57,890 At 31 December 2023 Cost 4,056 10,049 7,271 43,502 64,878 Accumulated impairments and depreciation (112) (4,374) (2,502) - (6,988)Net book value 3,944 5,675 4,769 43,502 57,890The Company\u2019s additions to the assets under construction mainly relates to the realization of a new state-of-the art megafactory for the production of our direct nanofiltration membranes. The additions to machinery and equipment mainly relate to expansion of the Company\u2019s production capacity. The additions to pilot equipment mainly relate to the expansion of its pilot fleet. The depreciation accounting policies for PP&E are included in the section accounting policies of the Company.", "dimensions": { "concept": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__81": { "value": "Right-of-use assetsThe movement in the right-of-use assets during the years was as follows:In EUR \u2018000 2023 2022At 1 January Cost 2,585 1,782 Accumulated depreciation (832) (426)Net book value 1,753 1,356 Additions 240 655 Other / remeasurement - 166 Disposals - (18)Depreciation of disposals - 18 Depreciation for the year (545) (424)Net book value at 31 December 1,448 1,753 Total gross right-of-use assets:31 December 31 DecemberIn EUR \u2018000 2023 2022Buildings 1,863 1,863 Vehicles 922 682 Fork-life truck 40 40 Total gross right-of-use assets 2,825 2,585 Total depreciation charge right-of-use assets:In EUR \u2018000 2023 2022Buildings 333 267 Vehicles 208 152 Fork-life truck 4 5 Total depreciation charge 545 424 Interest expense (included in finance cost) 65 61 The total cash outflow for leases in 2023 was \u20ac600 thousand (2022: \u20ac462 thousand).", "dimensions": { "concept": "ifrs-full:DisclosureOfLeasesExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__82": { "value": "Deferred tax assets31 December 31 DecemberIn EUR \u2018000 2023 2022Deferred tax assets Timing differences 16 13 Carry forward losses 0 8,947 Total 16 8,960 Of which: Current (<1 year) 16 13 Non-current (>1 year) 0 8,94731 December 31 DecemberIn EUR \u2018000 2023 2022Deferred tax assets At 1 January 8,960 5,708 Change in timing differences 3 4 Movement in loss compensation (8,947) 3,248 At 31 December 16 8,960 As of December 31, 2023, the amount of tax losses that can be offset in the future amounts to \u20ac48.7 million (\u20ac34.7 million per December 31, 2022). At 31 December 2023, the deferred tax assets have been fully derecognized. The remaining \u20ac16 thousand temporary difference is related to leases (right-of-use assets). In line with IFRS regulations and interpretations, management evaluated positive and negative evidence supporting the valuation of deferred tax assets for tax losses. The one and half year delay in the business plan, that the Company is currently anticipating, changed the balance in this assessment resulting in the derecognition of the deferred tax assets. Management emphasis that this assessment is not a change in its medium and long term targets. This derecognition has no cash implications and the tax losses remain available for the Company at the moment it starts to generate profits.", "dimensions": { "concept": "ifrs-full:DisclosureOfDeferredTaxesExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__83": { "value": "Inventories 31 December 31 DecemberIn EUR \u2018000 2023 2022Raw materials 5,114 2,186 Semi finished goods 3,189 1,428 Finished goods 6,409 1,976 Work in progress 351 715 Total 15,063 6,305 During 2023 no inventories were written down to net realizable value (31 December 2022: \u20ac nil).", "dimensions": { "concept": "ifrs-full:DisclosureOfInventoriesExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__84": { "value": "Trade and other receivables 31 December 31 DecemberIn EUR \u2018000 2023 2022Trade receivables 4,722 3,989 Less: loss allowance (42) (42)Trade receivables - net 4,680 3,947 Prepaid expenses 498 1,013 Other taxes 3,491 1,035 Other receivables 388 1,159 9,057 7,154 Less non-current portion - - Current portion 9,057 7,154 The fair value of the receivables approximates the carrying amounts. As at 31 December 2023 and 31 December 2022 mainly all receivables are denominated in euro currency. Information about the Company\u2019s exposure to credit and market risks, and impairment losses for trade and other receivables is included in note 3 \u2018Financial instruments and risk management\u2019.", "dimensions": { "concept": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__85": { "value": "Cash and cash equivalents 31 December 31 DecemberIn EUR \u2018000 2023 2022Cash and cash equivalents 49,928 104,274 Total 49,928 104,274 The cash and cash equivalents are freely disposable to the Company.", "dimensions": { "concept": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__88": { "value": "EquityOrdinary sharesThe movement of the ordinary shares in 2023 and 2022 is outlined in the tables below. Number of Par value Share premium Total ordinary shares EUR \u2018000 EUR \u2018000 EUR \u2018000Opening balance 1 January 2022 50,000,000 500 170,450 170,950 Share issuance - - - - Balance 31 December 2022 50,000,000 500 170,450 170,950 Share issuance 25,190 0 - - Balance 31 December 2023 50,025,190 500 170,450 170,950 The Company\u2019s issued capital amounted to \u20ac500,000 end of 2022, divided into 50,000,000 Ordinary Shares, The authorized capital (maatschappelijk kapitaal) of NX Filtration N.V. amounts to \u20ac1,750,000 divided into 175,000,000 ordinary shares.On 28 June 2023, the Company issued 25,190 ordinary shares to Stichting Bewaarneming Aandelen NX Filtration, for the purposes of a sign-on equity incentive for Mr. Pynenburg, as a result of which the Company\u2019s issued capital amounts to \u20ac500,251.90 divided into 50,025,190 Ordinary Shares.The share premium reserve relates to contribution on issued shares in excess of the nominal value of the shares (above par value)", "dimensions": { "concept": "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__86": { "value": "EquityOrdinary sharesThe movement of the ordinary shares in 2023 and 2022 is outlined in the tables below. Number of Par value Share premium Total ordinary shares EUR \u2018000 EUR \u2018000 EUR \u2018000Opening balance 1 January 2022 50,000,000 500 170,450 170,950 Share issuance - - - - Balance 31 December 2022 50,000,000 500 170,450 170,950 Share issuance 25,190 0 - - Balance 31 December 2023 50,025,190 500 170,450 170,950 The Company\u2019s issued capital amounted to \u20ac500,000 end of 2022, divided into 50,000,000 Ordinary Shares, The authorized capital (maatschappelijk kapitaal) of NX Filtration N.V. amounts to \u20ac1,750,000 divided into 175,000,000 ordinary shares.On 28 June 2023, the Company issued 25,190 ordinary shares to Stichting Bewaarneming Aandelen NX Filtration, for the purposes of a sign-on equity incentive for Mr. Pynenburg, as a result of which the Company\u2019s issued capital amounts to \u20ac500,251.90 divided into 50,025,190 Ordinary Shares.The share premium reserve relates to contribution on issued shares in excess of the nominal value of the shares (above par value). Retained earningsThe retained earnings are restricted due to a legal reserve for capitalized development costs of \u20ac2.2 million (31 December 2022: \u20ac2.1 million) which is not available for distribution.Loss for the period The proposal to the General Meeting is that the 2023 loss for the period will be recognized in retained earnings.", "dimensions": { "concept": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__87": { "value": "Retained earningsThe retained earnings are restricted due to a legal reserve for capitalized development costs of \u20ac2.2 million (31 December 2022: \u20ac2.1 million) which is not available for distribution.", "dimensions": { "concept": "ifrs-full:DisclosureOfReservesAndOtherEquityInterestExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__89": { "value": "Trade and other payables 31 December 31 DecemberIn EUR \u2018000 2023 2022Trade payables 13,039 3,029 Tax payables 316 231 Employee benefits 631 449 Payments received in advance 279 159 Other liabilities 809 1,120 Total 15,074 4,988 All current liabilities fall due in less than one year. The fair value of the current liabilities approximates the carrying amount due to its short-term character. The entire amount of payments received in advance has been recognized as income in the subsequent period.As at 31 December 2023 and 31 December 2022 the payables are mainly denominated in euro currency. The increase in trade payables is related to received invoices for our assets under construction.", "dimensions": { "concept": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__92": { "value": "Contingencies and commitments Capital Expenditure CommitmentsNX Filtration B.V. and NX Filtration Real Estate B.V. have signed a number of purchase contracts related to buildings, machinery and equipment capital expenditures, amounting to \u20ac20 million (2022: \u20ac45.9 million). Purchase commitmentsOutstanding commitments related to operating activities and the purchase of raw materials are amounting to \u20ac1.5 million.", "dimensions": { "concept": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__91": { "value": "Contingencies and commitments Capital Expenditure CommitmentsNX Filtration B.V. and NX Filtration Real Estate B.V. have signed a number of purchase contracts related to buildings, machinery and equipment capital expenditures, amounting to \u20ac20 million (2022: \u20ac45.9 million). Purchase commitmentsOutstanding commitments related to operating activities and the purchase of raw materials are amounting to \u20ac1.5 million.", "dimensions": { "concept": "ifrs-full:DisclosureOfCommitmentsExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__90": { "value": "Contingencies and commitments Capital Expenditure CommitmentsNX Filtration B.V. and NX Filtration Real Estate B.V. have signed a number of purchase contracts related to buildings, machinery and equipment capital expenditures, amounting to \u20ac20 million (2022: \u20ac45.9 million). Purchase commitmentsOutstanding commitments related to operating activities and the purchase of raw materials are amounting to \u20ac1.5 million.", "dimensions": { "concept": "ifrs-full:DisclosureOfContingentLiabilitiesExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__93": { "value": "Related party transactionsAll legal entities that can be controlled, jointly controlled or significantly influenced are considered to be a related party. Also, entities which can control, jointly control or significantly influence the Company are considered a related party. In addition, statutory and supervisory directors and close relatives are regarded as related parties.The following transactions were carried out with related parties:\u2022 Key management compensation, as further disclosed in note 16 above; \u2022 Management fee to Infestos Holding E B.V, based on the consultancy agreement between Infestos Holding E B.V. and NX Filtration as entered into on the date of IPO in the amount of \u20ac150 thousand;\u2022 The agreement with Polymer Filtration Solutions GmbH (PFS) which is a long-term supplier of sulfonated poly (ether sulfone) to NX Filtration. PFS is under the (indirect) control of Infestos Nederland B.V.All these transactions are made on terms equivalent to those that prevail in arm\u2019s length transactions.", "dimensions": { "concept": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } }, "s6_notes__6__94": { "value": "Events after the end of the reporting periodNo such events to report.", "dimensions": { "concept": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "language": "en", "entity": "scheme:254900YF0PQV9APMA050", "period": "2023-01-01T00:00:00/2024-01-01T00:00:00" } } } }